BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Halloran PF. Immunosuppressive Drugs for Kidney Transplantation. N Engl J Med 2004;351:2715-29. [DOI: 10.1056/nejmra033540] [Cited by in Crossref: 1057] [Cited by in F6Publishing: 1092] [Article Influence: 55.6] [Reference Citation Analysis]
Number Citing Articles
1 Singh D, Qasam I, Paudwal G, Kotwal P, Behera C, Kumar A, Gupta AP, Nandi U, Yadav G, Gupta PN, Shankar R. Redox-Responsive Hyaluronic Acid-Tacrolimus Conjugate: Synthesis, Characterization, and In Vitro Immunosuppressive Activity. ACS Appl Bio Mater 2023. [PMID: 36646666 DOI: 10.1021/acsabm.2c00946] [Reference Citation Analysis]
2 Madill-Thomsen KS, Böhmig GA, Bromberg J, Einecke G, Eskandary F, Gupta G, Myslak M, Viklicky O, Perkowska-Ptasinska A, Solez K, Halloran PF; INTERCOMEX Investigators. Relating Molecular T Cell- mediated Rejection Activity in Kidney Transplant Biopsies to Time and to Histologic Tubulitis and Atrophy-fibrosis. Transplantation 2022. [PMID: 36575574 DOI: 10.1097/TP.0000000000004396] [Reference Citation Analysis]
3 Zhao J, Jung S, Li X, Li L, Kasinath V, Zhang H, Movahedi SN, Mardini A, Sabiu G, Hwang Y, Saxena V, Song Y, Ma B, Acton SE, Kim P, Madsen JC, Sage PT, Tullius SG, Tsokos GC, Bromberg JS, Abdi R. Delivery of costimulatory blockade to lymph nodes promotes transplant acceptance in mice. J Clin Invest 2022;132. [PMID: 36519543 DOI: 10.1172/JCI159672] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Sallaberger S, Buchwinkler L, Eder S, Schneeberger S, Mayer G, Pirklbauer M. Population Characteristics and Clinical Outcomes from the Renal Transplant Outcome Prediction Validation Study (TOPVAS). J Clin Med 2022;11. [PMID: 36556037 DOI: 10.3390/jcm11247421] [Reference Citation Analysis]
5 Vela C, Jouve T, Chevallier E, Imerzoukene F, Germi R, Le Marechal M, Truffot A, Fiard G, Janbon B, Giovannini D, Malvezzi P, Rostaing L, Noble J. Conversion to mTOR-Inhibitors Plus IV Immunoglobulins in Kidney-Transplant Recipients with BKV Infection: A Retrospective Comparative Study. J Clin Med 2022;11. [PMID: 36555909 DOI: 10.3390/jcm11247292] [Reference Citation Analysis]
6 Llinàs-mallol L, Raïch-regué D, Pascual J, Crespo M. Alloimmune risk assessment for antibody-mediated rejection in kidney transplantation: A practical proposal. Transplantation Reviews 2022. [DOI: 10.1016/j.trre.2022.100745] [Reference Citation Analysis]
7 Wang J, Mao K, Cong X, Tan H, Wu C, Hu Z, Yang YG, Sun T. Nanoparticle delivery of CD40 siRNA suppresses alloimmune responses by inhibiting activation and differentiation of DCs and macrophages. Sci Adv 2022;8:eabq3699. [PMID: 36542700 DOI: 10.1126/sciadv.abq3699] [Reference Citation Analysis]
8 Frutos MÁ, Crespo M, Valentín MO, Alonso-Melgar Á, Alonso J, Fernández C, García-Erauzkin G, González E, González-Rinne AM, Guirado L, Gutiérrez-Dalmau A, Huguet J, Moral JLLD, Musquera M, Paredes D, Redondo D, Revuelta I, Hofstadt CJV, Alcaraz A, Alonso-Hernández Á, Alonso M, Bernabeu P, Bernal G, Breda A, Cabello M, Caro-Oleas JL, Cid J, Diekmann F, Espinosa L, Facundo C, García M, Gil-Vernet S, Lozano M, Mahillo B, Martínez MJ, Miranda B, Oppenheimer F, Palou E, Pérez-Saez MJ, Peri L, Rodríguez O, Santiago C, Tabernero G, Hernández D, Domínguez-Gil B, Pascual J. Recommendations for living donor kidney transplantation. Nefrologia (Engl Ed) 2022;42 Suppl 2:5-132. [PMID: 36503720 DOI: 10.1016/j.nefroe.2022.07.001] [Reference Citation Analysis]
9 Van Craenenbroeck AH, Koufaki P, Nagler EV, Segura-orti E, Kouidi EJ, Clyne N. Exercise training for adult kidney transplant recipients. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd014868] [Reference Citation Analysis]
10 Masset C, Dantal J, Soulillou JP, Walencik A, Delbos F, Brouard S, Giral M; Nantes DIVAT Consortium. Case Report: Long-term observations from the tacrolimus weaning randomized clinical trial depicts the challenging aspects for determination of low-immunological risk patients. Front Immunol 2022;13:1021481. [PMID: 36518770 DOI: 10.3389/fimmu.2022.1021481] [Reference Citation Analysis]
11 Oliveras L, Lopez-vargas P, Melilli E, Codina S, Royuela A, Coloma López A, Favà A, Manonelles A, Cruzado JM, Montero N. Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd014855] [Reference Citation Analysis]
12 Cheung J, Zahorowska B, Suranyi M, Wong JKW, Diep J, Spicer ST, Verma ND, Hodgkinson SJ, Hall BM. CD4+CD25+ T regulatory cells in renal transplantation. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1017683] [Reference Citation Analysis]
13 Cholbi Vives E, Espí Reig J, Cruz Sánchez A, Moreno Maestre E, Ventura Galiano A, Ramos Escorihuela D, Ramos Cebrián M, González-Calero Borrás P, Beneyto Castelló I, Hernández Jaras J. Comparative Study of 2 Extended-Release Tacrolimus Formulations in Kidney Transplantation. Transplant Proc 2022;54:2434-8. [PMID: 36334963 DOI: 10.1016/j.transproceed.2022.10.001] [Reference Citation Analysis]
14 Skulratanasak P, Larpparisuth N. Lipid management to mitigate poorer postkidney transplant outcomes. Current Opinion in Nephrology & Hypertension 2022;Publish Ahead of Print. [DOI: 10.1097/mnh.0000000000000841] [Reference Citation Analysis]
15 Wahl AK, Andersen MH, Ødemark J, Reisaether A, Urstad KH, Engebretsen E. The importance of shared meaning-making for sustainable knowledge translation and health literacy. J Eval Clin Pract 2022;28:828-34. [PMID: 35466469 DOI: 10.1111/jep.13690] [Reference Citation Analysis]
16 Kim MJ, Lim SJ, Ko Y, Kwon HE, Jung JH, Kwon H, Go H, Park Y, Kim T, Jung M, Pack C, Kim YH, Kim K, Shin S. Urinary Exosomal Cystatin C and Lipopolysaccharide Binding Protein as Biomarkers for Antibody−Mediated Rejection after Kidney Transplantation. Biomedicines 2022;10:2346. [DOI: 10.3390/biomedicines10102346] [Reference Citation Analysis]
17 Xuan NT, Hop VQ, Kien TQ, Toan PQ, Thang LV, Binh HT, Van Tran P, Minh HT, Man PT, Cuong HX, Ben NH, Phuong NM, Linh NT, Linh NT, Dung VD, Quyen LTB, Hang DTT, Su HX. Frequencies and Association of CYP3A5 Polymorphism With Tacrolimus Concentration Among Renal Transplant Recipients in Vietnam. Transplant Proc 2022:S0041-1345(22)00514-0. [PMID: 36085176 DOI: 10.1016/j.transproceed.2022.07.009] [Reference Citation Analysis]
18 Indini A, Fiorilla I, Ponzone L, Calautti E, Audrito V. NAD/NAMPT and mTOR Pathways in Melanoma: Drivers of Drug Resistance and Prospective Therapeutic Targets. IJMS 2022;23:9985. [DOI: 10.3390/ijms23179985] [Reference Citation Analysis]
19 Shao EX, Betz-Stablein B, Marquat L, Campbell S, Isbel N, Green AC, Plasmeijer EI. Higher mycophenolate dosage is associated with an increased risk of squamous cell carcinoma in kidney transplant recipients. Transpl Immunol 2022;75:101698. [PMID: 35988897 DOI: 10.1016/j.trim.2022.101698] [Reference Citation Analysis]
20 Kervella D, Le Bas-bernardet S, Bruneau S, Blancho G. Protection of transplants against antibody-mediated injuries: from xenotransplantation to allogeneic transplantation, mechanisms and therapeutic insights. Front Immunol 2022;13:932242. [DOI: 10.3389/fimmu.2022.932242] [Reference Citation Analysis]
21 Jang S, Oh B, Nam JH, Lee E, Kim H, Kwon S. Clinical impact and economic burden of post-transplant infections following heart transplantation: a retrospective nationwide cohort study. The Journal of Heart and Lung Transplantation 2022. [DOI: 10.1016/j.healun.2022.08.001] [Reference Citation Analysis]
22 Arisu Naghavi E, Goker Bagca B, Tekeli S, Yiğittürk G, Gökçe B, Tomruk C, Çavuşoğlu T, Avci Ç, Gündüz C, Uyanikgil Y. URSODEOKSİKOLİK ASİTİN SİROLİMUS UYGULANAN YAĞ DOKUSU KÖKENLİ MEZENKİMAL KÖK HÜCRELER ÜZERİNE ETKİLERİNİN İNCELENMESİ. SDÜ Tıp Fakültesi Dergisi 2022. [DOI: 10.17343/sdutfd.1077520] [Reference Citation Analysis]
23 Michou V, Nikodimopoulou M, Deligiannis A, Kouidi E. Metabolic and functional effects of exercise training in diabetic kidney transplant recipients. World J Transplant 2022; 12(7): 184-194 [DOI: 10.5500/wjt.v12.i7.184] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Liu SJ, Ma K, Liu LS, Wang K, Zhang YA, Bi ZR, Chen YX, Chen KZ, Wang CX, Qiao SL. Point-of-care non-invasive enzyme-cleavable nanosensors for acute transplant rejection detection. Biosens Bioelectron 2022;215:114568. [PMID: 35850041 DOI: 10.1016/j.bios.2022.114568] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Sen T, Thummer RP. The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation. Front Immunol 2022;13:932228. [DOI: 10.3389/fimmu.2022.932228] [Reference Citation Analysis]
26 Li X, Kong D, Yu Q, Si X, Yang L, Zeng X, Li Y, Shi J, Qian P, Huang H, Lin Y. Cyclosporine A regulates PMN-MDSCs viability and function through MPTP in acute GVHD: Old medication, new target. Transplant Cell Ther 2022;28:411.e1-9. [PMID: 35430420 DOI: 10.1016/j.jtct.2022.04.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Galato D, Simões IG, Soares LSDS. Evaluación del Índice de Complejidad de la Farmacoterapia en Pacientes de un Ambulatorio de Transplante Renal. BJT 2022;25. [DOI: 10.53855/bjt.v25i2.448_esp] [Reference Citation Analysis]
28 Galato D, Simões IG, Soares LSDS. Avaliação do Índice de Complexidade da Farmacoterapia em Pacientes de um Ambulatório de Transplante Renal. BJT 2022;25. [DOI: 10.53855/bjt.v25i2.448_pt] [Reference Citation Analysis]
29 Galato D, Simões IG, Soares LSDS. Evaluation of the Pharmacotherapy Complexity Index in Patients of a Renal Transplant Clinic. BJT 2022;25. [DOI: 10.53855/bjt.v25i2.448_en] [Reference Citation Analysis]
30 Alladin BA, Pfister K, Hodson EM, Hahn D, Ravani P, Quinn RR, Samuel SM. Immunosuppressive therapy for IgA nephropathy in children. Cochrane Database of Systematic Reviews 2022;2022. [DOI: 10.1002/14651858.cd015060] [Reference Citation Analysis]
31 Gille I, Claas FHJ, Haasnoot GW, Heemskerk MHM, Heidt S. Chimeric Antigen Receptor (CAR) Regulatory T-Cells in Solid Organ Transplantation. Front Immunol 2022;13:874157. [PMID: 35720402 DOI: 10.3389/fimmu.2022.874157] [Reference Citation Analysis]
32 Mani LY, Cotting J, Vogt B, Eisenberger U, Vermathen P. Influence of Immunosuppressive Regimen on Diffusivity and Oxygenation of Kidney Transplants-Analysis of Functional MRI Data from the Randomized ZEUS Trial. J Clin Med 2022;11:3284. [PMID: 35743353 DOI: 10.3390/jcm11123284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Park J, Jung BH. Future-directed studies on immunosuppressive treatments and xenografts for organ transplantation. Ann Liver Transplant 2022;2:1-7. [DOI: 10.52604/alt.22.0003] [Reference Citation Analysis]
34 Altneu E, Mishkin A. COVID-19 Vaccination in Lung Transplant Recipients. Indian J Thorac Cardiovasc Surg. [DOI: 10.1007/s12055-022-01364-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
35 Van Loon E, Lamarthée B, de Loor H, Van Craenenbroeck AH, Brouard S, Danger R, Giral M, Callemeyn J, Tinel C, Cortés Calabuig Á, Koshy P, Sprangers B, Kuypers D, Gwinner W, Anglicheau D, Marquet P, Naesens M. Biological pathways and comparison with biopsy signals and cellular origin of peripheral blood transcriptomic profiles during kidney allograft pathology. Kidney International 2022. [DOI: 10.1016/j.kint.2022.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
36 Qi WH, Zhang YY, Xing K, Hao DX, Zhang F, Wang RN, Bao MY, Tian MY, Yang YN, Li X, Zhang Y. 2', 4'-Dihydroxy-2,3-dimethoxychalcone: A pharmacological inverse agonist of RORγt ameliorating Th17-driven inflammatory diseases by regulating Th17/Treg. Int Immunopharmacol 2022;108:108769. [PMID: 35453073 DOI: 10.1016/j.intimp.2022.108769] [Reference Citation Analysis]
37 Ningappa M, Rahman SA, Higgs BW, Ashokkumar CS, Sahni N, Sindhi R, Das J. A network-based approach to identify expression modules underlying rejection in pediatric liver transplantation. Cell Rep Med 2022;3:100605. [PMID: 35492246 DOI: 10.1016/j.xcrm.2022.100605] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Mani L, Cotting J, Vogt B, Eisenberger U, Vermathen P. Influence of immunosuppressive regimen on diffusivity and oxygenation of kidney transplants – analysis of functional MRI data from the randomized ZEUS trial.. [DOI: 10.1101/2022.04.11.22273639] [Reference Citation Analysis]
39 Di Meo A, Youkhana S, Khalifeh S, Brinc D. Evaluation of a batched-extraction method for measurement of sirolimus, tacrolimus, and cyclosporine on the Architect i2000SR. Clin Chim Acta 2022:S0009-8981(22)00118-8. [PMID: 35390337 DOI: 10.1016/j.cca.2022.03.027] [Reference Citation Analysis]
40 Frutos MÁ, Crespo M, Valentín MDLO, Alonso-melgar Á, Alonso J, Fernández C, García-erauzkin G, González E, González-rinne AM, Guirado L, Gutiérrez-dalmau A, Huguet J, López del Moral JL, Musquera M, Paredes D, Redondo D, Revuelta I, Van-der Hofstadt CJ, Alcaraz A, Alonso-hernández Á, Alonso M, Bernabeu P, Bernal G, Breda A, Cabello M, Caro-oleas JL, Cid J, Diekmann F, Espinosa L, Facundo C, García M, Gil-vernet S, Lozano M, Mahillo B, Martínez MJ, Miranda B, Oppenheimer F, Palou E, Pérez-saez MJ, Peri L, Rodríguez O, Santiago C, Tabernero G, Hernández D, Domínguez-gil B, Pascual J. Recomendaciones para el trasplante renal de donante vivo. Nefrología 2022;42:1-128. [DOI: 10.1016/j.nefro.2021.10.002] [Reference Citation Analysis]
41 Budde K, Rostaing L, Maggiore U, Piotti G, Surace D, Geraci S, Procaccianti C, Nicolini G, Witzke O, Kamar N, Albano L, Büchler M, Pascual J, Gutiérrez-dalmau A, Kuypers D, Wekerle T, Głyda M, Carmellini M, Tisone G, Midtvedt K, Wennberg L, Grinyó JM. Prolonged-Release Once-Daily Formulation of Tacrolimus Versus Standard-of-Care Tacrolimus in de novo Kidney Transplant Patients Across Europe. Transpl Int 2022;35:10225. [DOI: 10.3389/ti.2021.10225] [Reference Citation Analysis]
42 Peng B, Luo Y, Zhuang Q, Li J, Zhang P, Yang M, Zhang Y, Kong G, Cheng K, Ming Y. The Expansion of Myeloid-Derived Suppressor Cells Correlates With the Severity of Pneumonia in Kidney Transplant Patients. Front Med (Lausanne) 2022;9:795392. [PMID: 35242775 DOI: 10.3389/fmed.2022.795392] [Reference Citation Analysis]
43 Beck H, Härter M, Haß B, Schmeck C, Baerfacker L. Small molecules and their impact in drug discovery: A perspective on the occasion of the 125th anniversary of the Bayer Chemical Research Laboratory. Drug Discov Today 2022:S1359-6446(22)00073-3. [PMID: 35202802 DOI: 10.1016/j.drudis.2022.02.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
44 Maurer MM, Ibach M, Plewe J, Winter A, Ritschl P, Globke B, Öllinger R, Lurje G, Schöning W, Pratschke J, Eurich D. Reducing the Pill Burden: Immunosuppressant Adherence and Safety after Conversion from a Twice-Daily (IR-Tac) to a Novel Once-Daily (LCP-Tac) Tacrolimus Formulation in 161 Liver Transplant Patients. Biomedicines 2022;10:272. [DOI: 10.3390/biomedicines10020272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Kim M, Lim J, Han M, Kim S, Kim YJ, Kim Y. Multiplex Immunofluorescence Assay of Infiltrating Mononu-Clear Cell Subsets in Acute T-Cell-Mediated Rejection and BK Virus-Associated Nephropathy in the Allograft Kidney. Diagnostics 2022;12:268. [DOI: 10.3390/diagnostics12020268] [Reference Citation Analysis]
46 Burke JA, Zhang X, Bobbala S, Frey MA, Bohorquez Fuentes C, Freire Haddad H, Allen SD, Richardson RAK, Ameer GA, Scott EA. Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability. Nat Nanotechnol 2022. [PMID: 35039683 DOI: 10.1038/s41565-021-01048-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 11.0] [Reference Citation Analysis]
47 Luo Y, Teng F, Fu H, Ding GS. Immunotherapy in liver transplantation for hepatocellular carcinoma: Pros and cons. World J Gastrointest Oncol 2022; 14(1): 163-180 [DOI: 10.4251/wjgo.v14.i1.163] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
48 Tönshoff B, Sarwal M, Marks SD, Moudgil A. Renal Transplantation: Immunosuppression and Managing Allograft Rejection. Pediatric Nephrology 2022. [DOI: 10.1007/978-3-030-52719-8_136] [Reference Citation Analysis]
49 Cavalli AC, Sala LFM, Slongo J, Fraga RD, Tambara Filho R. Evaluation of nefrotoxicity by tacrolimus and micophenolate mofetil associated with kidney ischemia and reperfusion: experimental study in rats. Rev Col Bras Cir 2022;49. [DOI: 10.1590/0100-6991e-20223233-en] [Reference Citation Analysis]
50 Blanchard-rohner G, Pittet LF. Immune Responses to Vaccination. In Clinical Practice 2022. [DOI: 10.1007/978-3-031-04844-9_2] [Reference Citation Analysis]
51 Shi X. Immunosuppressive Strategies in Transplantation Using Cardiac Death Donors. Organ Donation and Transplantation after Cardiac Death in China 2022. [DOI: 10.1007/978-981-16-0815-5_10] [Reference Citation Analysis]
52 Groves HK, Lee H. Perioperative Management of Renal Failure and Renal Transplant. Perioperative Medicine 2022. [DOI: 10.1016/b978-0-323-56724-4.00019-8] [Reference Citation Analysis]
53 Macphee IAM. Immunosuppression for Renal Transplantation. Primer on Nephrology 2022. [DOI: 10.1007/978-3-030-76419-7_93] [Reference Citation Analysis]
54 Silva HT. Immunosuppression and Solid Organ Transplantation. Atlas of Dermatologic Diseases in Solid Organ Transplant Recipients 2022. [DOI: 10.1007/978-3-031-13335-0_1] [Reference Citation Analysis]
55 Panackel C, Mathew JF, Fawas N M, Jacob M. Immunosuppressive Drugs in Liver Transplant: An Insight. J Clin Exp Hepatol 2022;12:1557-71. [PMID: 36340316 DOI: 10.1016/j.jceh.2022.06.007] [Reference Citation Analysis]
56 Nikolova A, Patel JK. Induction Therapy and Therapeutic Antibodies. Pharmacology of Immunosuppression 2022. [DOI: 10.1007/164_2021_570] [Reference Citation Analysis]
57 Dai H, Chen S, Kowalewska J. Educational Case: Renal allograft rejection. Academic Pathology 2022;9:100013. [DOI: 10.1016/j.acpath.2022.100013] [Reference Citation Analysis]
58 Cavalli AC, Sala LFM, Slongo J, Fraga RD, Tambara Filho R. Avaliação da nefrotoxicidade pelo tacrolimus e micofenolato mofetil associados à isquemia e reperfusão renal: estudo experimental em ratos. Rev Col Bras Cir 2022;49. [DOI: 10.1590/0100-6991e-20223233] [Reference Citation Analysis]
59 Callemeyn J, Lamarthée B, Koenig A, Koshy P, Thaunat O, Naesens M. Allorecognition and the spectrum of kidney transplant rejection. Kidney Int 2021:S0085-2538(21)01143-1. [PMID: 34915041 DOI: 10.1016/j.kint.2021.11.029] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
60 Ayyadurai VAS, Deonikar P. Bioactive compounds in green tea may improve transplant tolerance: A computational systems biology analysis. Clin Nutr ESPEN 2021;46:439-52. [PMID: 34857232 DOI: 10.1016/j.clnesp.2021.09.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
61 Yadav DK, Adhikari VP, Ling Q, Liang T. Immunosuppressants in Liver Transplant Recipients With Coronavirus Disease 2019: Capability or Catastrophe?-A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021;8:756922. [PMID: 34859012 DOI: 10.3389/fmed.2021.756922] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
62 Shigematsu T, Tajima S, Fu R, Zhang M, Itoyama Y, Tsuchimoto A, Egashira N, Ieiri I. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci 2021;288:120150. [PMID: 34793770 DOI: 10.1016/j.lfs.2021.120150] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
63 Mallina H, Elumalai R, F D Paul S, George Priya Doss C, Udhaya Kumar S, Ramanathan G. Computational validation of ABCB1 gene polymorphism and its effect on tacrolimus dose concentration/levels in renal transplant individuals of South India. Comput Biol Med 2021;139:104971. [PMID: 34735949 DOI: 10.1016/j.compbiomed.2021.104971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Ho CJ, Huang YH, Hsieh TY, Yang MH, Wang SC, Chen WJ, Lee TH, Sung WW, Chen SL. Native Kidney Hydronephrosis Is Associated with Upper Urinary Tract Urothelial Carcinoma in Post-Kidney Transplantation Patients. J Clin Med 2021;10:4474. [PMID: 34640492 DOI: 10.3390/jcm10194474] [Reference Citation Analysis]
65 Tedesco-Silva H, Saliba F, Barten MJ, De Simone P, Potena L, Gottlieb J, Gawai A, Bernhardt P, Pascual J. An overview of the efficacy and safety of everolimus in adult solid organ transplant recipients. Transplant Rev (Orlando) 2021;:100655. [PMID: 34696930 DOI: 10.1016/j.trre.2021.100655] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
66 Varga Z, Tajti G, Panyi G. The Kv1.3 K+ channel in the immune system and its "precision pharmacology" using peptide toxins. Biol Futur 2021;72:75-83. [PMID: 34554500 DOI: 10.1007/s42977-021-00071-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
67 Kopecky B, Dun H, Amrute J, Lin C, Bredemeyer A, Terada Y, Bayguinov P, Koenig A, Frye C, Fitzpatrick J, Kreisel D, Lavine K. Donor Macrophages Modulate Rejection after Heart Transplantation.. [DOI: 10.1101/2021.09.17.459296] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Suzuki Y, Yoshihashi T, Takahashi K, Furuya K, Ohkohchi N, Oda T, Homma M. Drug-Drug Interaction between Tacrolimus and Vonoprazan in Kidney Transplant Recipients. J Clin Med 2021;10:3964. [PMID: 34501411 DOI: 10.3390/jcm10173964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
69 Parlakpinar H, Gunata M. Transplantation and immunosuppression: a review of novel transplant-related immunosuppressant drugs. Immunopharmacol Immunotoxicol 2021;43:651-65. [PMID: 34415233 DOI: 10.1080/08923973.2021.1966033] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
70 Blanchard-Rohner G. Vaccination in Children With Autoimmune Disorders and Treated With Various Immunosuppressive Regimens: A Comprehensive Review and Practical Guide. Front Immunol 2021;12:711637. [PMID: 34408752 DOI: 10.3389/fimmu.2021.711637] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
71 Olaso D, Manook M, Moris D, Knechtle S, Kwun J. Optimal Immunosuppression Strategy in the Sensitized Kidney Transplant Recipient. J Clin Med 2021;10:3656. [PMID: 34441950 DOI: 10.3390/jcm10163656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
72 Hou YC, Lu KC, Kuo KL. The Efficacy of COVID-19 Vaccines in Chronic Kidney Disease and Kidney Transplantation Patients: A Narrative Review. Vaccines (Basel) 2021;9:885. [PMID: 34452010 DOI: 10.3390/vaccines9080885] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
73 Wubetu JT, Brown CE, Clancy M. The immunology of solid organ transplantation. Anaesthesia & Intensive Care Medicine 2021;22:522-525. [DOI: 10.1016/j.mpaic.2021.06.010] [Reference Citation Analysis]
74 Mehta TI, Kurman J, Dolan S, Gill H, Thapa B. Blastomycosis in solid organ transplant recipients-A retrospective series from southeastern Wisconsin. Transpl Infect Dis 2021;23:e13671. [PMID: 34146378 DOI: 10.1111/tid.13671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
75 Petrash CC, Palestine AG, Canto-Soler MV. Immunologic Rejection of Transplanted Retinal Pigmented Epithelium: Mechanisms and Strategies for Prevention. Front Immunol 2021;12:621007. [PMID: 34054796 DOI: 10.3389/fimmu.2021.621007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
76 Rodríguez IBT, Roig JS, Carrascosa MP, Mateos FM. Recomendaciones en el seguimiento del trasplantado renal. FMC - Formación Médica Continuada en Atención Primaria 2021;28:289-294. [DOI: 10.1016/j.fmc.2020.10.008] [Reference Citation Analysis]
77 Tziastoudi M, Pissas G, Raptis G, Cholevas C, Eleftheriadis T, Dounousi E, Stefanidis I, Theoharides TC. A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease. Int J Mol Sci 2021;22:4480. [PMID: 33923087 DOI: 10.3390/ijms22094480] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
78 Bunnapradist S, Datta N, Schaenman J, Ioannou N, Bloom MS, Malhotra M, Tabriziani H, Gauthier P, Ahmed E, Billings PR, Lum EL. Extremely High Cell-free DNA Levels Observed in Renal Allograft Patient With SARS-CoV-2 Infection. Transplant Direct 2021;7:e691. [PMID: 33912658 DOI: 10.1097/TXD.0000000000001145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
79 Gras J, Abdel-Nabey M, Dupont A, Le Goff J, Molina JM, Peraldi MN. Clinical characteristics, risk factors and outcome of severe Norovirus infection in kidney transplant patients: a case-control study. BMC Infect Dis 2021;21:351. [PMID: 33858369 DOI: 10.1186/s12879-021-06062-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Alfieri CM, Molinari P, Gandolfo M, Campise M, Cresseri D, Regalia A, Favi E, Li M, Ikehata M, Delbue S, Messa P. Cytomegalovirus Disease in Renal Transplanted Patients: Prevalence, Determining Factors, and Influence on Graft and Patients Outcomes. Pathogens 2021;10:473. [PMID: 33919676 DOI: 10.3390/pathogens10040473] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
81 Cechlárová K, Hančová M, Plačková D, Baltesová T. Stochastic modelling and simulation of a kidney transplant waiting list. Cent Eur J Oper Res 2021;29:909-31. [DOI: 10.1007/s10100-021-00742-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
82 Schuchardt M, Herrmann J, Henkel C, Babic M, van der Giet M, Tölle M. Long-Term Treatment of Azathioprine in Rats Induces Vessel Mineralization. Biomedicines 2021;9:327. [PMID: 33806932 DOI: 10.3390/biomedicines9030327] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
83 El Hage A, Dormond O. Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment. Cancers (Basel) 2021;13:1359. [PMID: 33802831 DOI: 10.3390/cancers13061359] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
84 Mahr B, Pilat N, Granofszky N, Muckenhuber M, Unger LW, Weijler AM, Wiletel M, Steiner R, Dorner L, Regele H, Wekerle T. Distinct roles for major and minor antigen barriers in chimerism-based tolerance under irradiation-free conditions. Am J Transplant 2021;21:968-77. [PMID: 32633070 DOI: 10.1111/ajt.16177] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Zhuang J, Hou J. The Role of Regulatory Myeloid Cell Therapy in Renal Allograft Rejection. Front Immunol 2021;12:625998. [PMID: 33717141 DOI: 10.3389/fimmu.2021.625998] [Reference Citation Analysis]
86 De Smet S, Van Craenenbroeck AH. Exercise training in patients after kidney transplantation. Clin Kidney J 2021;14:ii15-24. [PMID: 33981416 DOI: 10.1093/ckj/sfab022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
87 Hsiao CY, Ho MC, Ho CM, Wu YM, Lee PH, Hu RH. Long-Term Tacrolimus Blood Trough Level and Patient Survival in Adult Liver Transplantation. J Pers Med 2021;11:90. [PMID: 33535628 DOI: 10.3390/jpm11020090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Watanabe ALC, Matias JEF. DOES THE ASSOCIATION OF TACROLIMUS AND MYCOPHENOLATE MOFETIL CHANGE THE HEALING OF THE ABDOMINAL WALL? STUDY IN RATS SUBMITTED TO ISCHEMIA AND KIDNEY REPERFUSION. Arq Bras Cir Dig 2021;33:e1551. [PMID: 33503111 DOI: 10.1590/0102-672020200004e1551] [Reference Citation Analysis]
89 Gunawardana H, Romero T, Yao N, Heidt S, Mulder A, Elashoff DA, Valenzuela NM. Tissue-specific endothelial cell heterogeneity contributes to unequal inflammatory responses. Sci Rep 2021;11:1949. [PMID: 33479269 DOI: 10.1038/s41598-020-80102-w] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
90 Jarmi T, Khouzam S, Shekhar N, Hosni M, White L, Hodge DO, Mai ML, Wadei HM. The Impact of Different Induction Immunosuppressive Therapy on Long-Term Kidney Transplant Function When Measured by Iothalamate Clearance. J Clin Med Res 2020;12:787-93. [PMID: 33447312 DOI: 10.14740/jocmr4369] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Hoogduijn MJ, Issa F, Casiraghi F, Reinders MEJ. Cellular therapies in organ transplantation. Transpl Int 2021;34:233-44. [PMID: 33207013 DOI: 10.1111/tri.13789] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
92 Lim LM, Kung LF, Kuo MC, Huang AM, Kuo HT. Timing of mTORI usage and outcomes in kidney transplant recipients. Int J Med Sci 2021;18:1179-84. [PMID: 33526978 DOI: 10.7150/ijms.53655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
93 Everton JBF, Patrício FJB, Faria MS, Ferreira TCA, Romao EA, Silva GEB, Magalhães M. CYP3A5 and PPARA genetic variants are associated with low trough concentration to dose ratio of tacrolimus in kidney transplant recipients. Eur J Clin Pharmacol 2021;77:879-86. [PMID: 33398393 DOI: 10.1007/s00228-020-03076-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
94 Siddiqi N, Campbell A. Post-transplant Medication Challenges. Challenges in Pediatric Kidney Transplantation 2021. [DOI: 10.1007/978-3-030-74783-1_12] [Reference Citation Analysis]
95 Marin EP, Colegio O. Immunosuppressive Pharmacology. Transplantation Surgery 2021. [DOI: 10.1007/978-3-030-55244-2_20] [Reference Citation Analysis]
96 Parrado RH, Nadig SN. Challenges Surrounding Induction Protocols in Children. Challenges in Pediatric Kidney Transplantation 2021. [DOI: 10.1007/978-3-030-74783-1_11] [Reference Citation Analysis]
97 Bello A, Vandermeer B, Wiebe N, Garg AX, Tonelli M. Evidence-Based Decision-Making 2: Systematic Reviews and Meta-Analysis. Methods Mol Biol 2021;2249:405-28. [PMID: 33871856 DOI: 10.1007/978-1-0716-1138-8_22] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
98 Lam NN, Sarabu N, Habbous S, Garg AX. Rationale and Landscape of Living Kidney Donation in Contemporary Practice. Living Kidney Donation 2021. [DOI: 10.1007/978-3-030-53618-3_1] [Reference Citation Analysis]
99 Halloran PF, Einecke G, Sikosana MLN, Madill-thomsen K. The Biology and Molecular Basis of Organ Transplant Rejection. Pharmacology of Immunosuppression 2021. [DOI: 10.1007/164_2021_557] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
100 Chang Y, Barbas A. The surgical and immunosuppressive basis for infections in the pediatric solid organ transplant recipient. Pediatric Transplant and Oncology Infectious Diseases 2021. [DOI: 10.1016/b978-0-323-64198-2.00010-5] [Reference Citation Analysis]
101 Campbell PM, Humphreys GJ, Summers AM, Konkel JE, Knight CG, Augustine T, McBain AJ. Does the Microbiome Affect the Outcome of Renal Transplantation? Front Cell Infect Microbiol 2020;10:558644. [PMID: 33425774 DOI: 10.3389/fcimb.2020.558644] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
102 Carminatti M, Fernandes NMS, Colugnati FAB, Sanders-Pinheiro H. Similar quality in chronic kidney disease multidisciplinary follow-up between kidney. J Bras Nefrol 2021;43:318-29. [PMID: 33346316 DOI: 10.1590/2175-8239-JBN-2019-0239] [Reference Citation Analysis]
103 Brosda J, Becker T, Richter M, Jakobs M, Hörbelt T, Bendix I, Lückemann L, Schedlowski M, Hadamitzky M. Treatment with the calcineurin inhibitor and immunosuppressant cyclosporine A impairs sensorimotor gating in Dark Agouti rats. Psychopharmacology (Berl) 2021;238:1047-57. [PMID: 33349900 DOI: 10.1007/s00213-020-05751-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
104 Barahona-correa JE, De la Hoz A, López MJ, Garzón J, Allanore Y, Quintana-lópez G. Infecciones y esclerosis sistémica: un desafío emergente. Revista Colombiana de Reumatología 2020;27:62-84. [DOI: 10.1016/j.rcreu.2019.12.007] [Reference Citation Analysis]
105 Bagheri A, Moezzi SMI, Mosaddeghi P, Nadimi Parashkouhi S, Fazel Hoseini SM, Badakhshan F, Negahdaripour M. Interferon-inducer antivirals: Potential candidates to combat COVID-19. Int Immunopharmacol 2021;91:107245. [PMID: 33348292 DOI: 10.1016/j.intimp.2020.107245] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
106 Roemhild A, Otto NM, Moll G, Abou-El-Enein M, Kaiser D, Bold G, Schachtner T, Choi M, Oellinger R, Landwehr-Kenzel S, Juerchott K, Sawitzki B, Giesler C, Sefrin A, Beier C, Wagner DL, Schlickeiser S, Streitz M, Schmueck-Henneresse M, Amini L, Stervbo U, Babel N, Volk HD, Reinke P. Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trial. BMJ 2020;371:m3734. [PMID: 33087345 DOI: 10.1136/bmj.m3734] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 18.7] [Reference Citation Analysis]
107 Yong KSM, Her Z, Tan SY, Tan WWS, Liu M, Lai F, Heng SM, Fan Y, Chang KTE, Wang CI, Chan JKY, Chen J, Chen Q. Humanized Mouse as a Tool to Predict Immunotoxicity of Human Biologics. Front Immunol 2020;11:553362. [PMID: 33193321 DOI: 10.3389/fimmu.2020.553362] [Reference Citation Analysis]
108 Jeong R, Quinn RR, Lentine KL, Ravani P, Ye F, Campbell P, Wen K, Broscheit C, Gourishankar S, Lam NN. Incidence, Risk Factors, and Outcomes of Kidney Transplant Recipients Treated With Both Basiliximab and Antithymocyte Globulin. Can J Kidney Health Dis 2020;7:2054358120964061. [PMID: 33117549 DOI: 10.1177/2054358120964061] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
109 Chu J, Ellis S, Wong J, Parker K. Prescribing in patients with kidney disease. Journal of Prescribing Practice 2020;2:535-544. [DOI: 10.12968/jprp.2020.2.10.535] [Reference Citation Analysis]
110 Kemmner S, Schönermarck U. Infektionen unter Immunsuppression nach Nierentransplantation. Dialyse aktuell 2020;24:309-318. [DOI: 10.1055/a-1176-6416] [Reference Citation Analysis]
111 Burke JA, Zhang X, Reddy Bobbala SK, Frey MA, Fuentes CB, Haddad HF, Allen SD, Richardson RA, Ameer GA, Scott EA. Subcutaneous nanotherapy repurposes the immunosuppressive mechanism of rapamycin to enhance allogeneic islet graft viability.. [DOI: 10.1101/2020.09.03.281923] [Reference Citation Analysis]
112 Leino AD, Pai MP. Maintenance Immunosuppression in Solid Organ Transplantation: Integrating Novel Pharmacodynamic Biomarkers to Inform Calcineurin Inhibitor Dose Selection. Clin Pharmacokinet 2020;59:1317-34. [PMID: 32720300 DOI: 10.1007/s40262-020-00923-w] [Reference Citation Analysis]
113 Shah S, DeBerge M, Iovane A, Yan S, Qiu L, Wang JJ, Kanwar YS, Hummel M, Zhang ZJ, Abecassis MM, Luo X, Thorp EB. MCMV Dissemination from Latently-Infected Allografts Following Transplantation into Pre-Tolerized Recipients. Pathogens 2020;9:E607. [PMID: 32722544 DOI: 10.3390/pathogens9080607] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
114 Seo Y, Mun CH, Park SH, Jeon D, Kim SJ, Yoon T, Ko E, Jo S, Park YB, Namkung W, Lee SW. Punicalagin Ameliorates Lupus Nephritis via Inhibition of PAR2. Int J Mol Sci 2020;21:E4975. [PMID: 32674502 DOI: 10.3390/ijms21144975] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
115 Hörbelt T, Hetze S, Schedlowski M, Lückemann L. [The learned placebo response in the immune system]. Nervenarzt 2020;91:667-74. [PMID: 32642946 DOI: 10.1007/s00115-020-00945-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
116 Callemeyn J, Lerut E, de Loor H, Arijs I, Thaunat O, Koenig A, Meas-Yedid V, Olivo-Marin JC, Halloran P, Chang J, Thorrez L, Kuypers D, Sprangers B, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies. J Am Soc Nephrol 2020;31:2168-83. [PMID: 32641395 DOI: 10.1681/ASN.2020030306] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
117 Noguchi H, Tsuchimoto A, Ueki K, Kaku K, Okabe Y, Nakamura M. Reduced Recurrence of Primary IgA Nephropathy in Kidney Transplant Recipients Receiving Everolimus With Corticosteroid: A Retrospective, Single-Center Study of 135 Transplant Patients. Transplant Proc 2020;52:3118-24. [PMID: 32600641 DOI: 10.1016/j.transproceed.2020.05.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Kahnamuee HR, Fesharaki RJ. Hair Transplantation in a Patient with a Renal Transplant. Hair Transplant Forum International 2020;30:132-133. [DOI: 10.33589/30.4.132] [Reference Citation Analysis]
119 Otsuka R, Wada H, Murata T, Seino KI. Immune reaction and regulation in transplantation based on pluripotent stem cell technology. Inflamm Regen 2020;40:12. [PMID: 32636970 DOI: 10.1186/s41232-020-00125-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
120 Colazo JM, Evans BC, Farinas AF, Al-Kassis S, Duvall CL, Thayer WP. Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration. Tissue Eng Part B Rev 2019;25:259-90. [PMID: 30896342 DOI: 10.1089/ten.TEB.2018.0325] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
121 Wu H, Singer J, Kwan TK, Loh YW, Wang C, Tan J, Li YJ, Lai SWC, Macia L, Alexander SI, Chadban SJ. Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids. J Am Soc Nephrol. 2020;31:1445-1461. [PMID: 32482686 DOI: 10.1681/asn.2019080852] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
122 Shiraishi Y, Amiya E, Hatano M, Katsuki T, Bujo C, Tsuji M, Nitta D, Maki H, Ishida J, Kagami Y, Endo M, Kimura M, Ando M, Shimada S, Kinoshita O, Ono M, Komuro I. Impact of tacrolimus versus cyclosporin A on renal function during the first year after heart transplant. ESC Heart Fail 2020;7:1842-9. [PMID: 32445260 DOI: 10.1002/ehf2.12749] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
123 Park JB. Future direction of immunosuppressive treatment in organ transplantation. J Korean Med Assoc 2020;63:259-266. [DOI: 10.5124/jkma.2020.63.5.259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Lim SW, Luo K, Quan Y, Cui S, Shin YJ, Ko EJ, Chung BH, Yang CW. The safety, immunological benefits, and efficacy of ginseng in organ transplantation. J Ginseng Res 2020;44:399-404. [PMID: 32372861 DOI: 10.1016/j.jgr.2020.02.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
125 Cheng CH, Lee CF, Oh BC, Furtmüller GJ, Patel CH, Brandacher G, Powell JD. Targeting Metabolism as a Platform for Inducing Allograft Tolerance in the Absence of Long-Term Immunosuppression. Front Immunol 2020;11:572. [PMID: 32328063 DOI: 10.3389/fimmu.2020.00572] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
126 Wagner MJ, Khan M, Mohsin S. Healing the Broken Heart; The Immunomodulatory Effects of Stem Cell Therapy. Front Immunol 2020;11:639. [PMID: 32328072 DOI: 10.3389/fimmu.2020.00639] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
127 Barahona-correa JE, De la Hoz A, López MJ, Garzón J, Allanore Y, Quintana-lópez G. Infections and systemic sclerosis: an emerging challenge. Revista Colombiana de Reumatología (English Edition) 2020;27:62-84. [DOI: 10.1016/j.rcreue.2019.12.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
128 Axelrod DA, Caliskan Y, Schnitzler MA, Xiao H, Dharnidharka VR, Segev DL, Mcadams‐demarco M, Brennan DC, Randall H, Alhamad T, Kasiske BL, Hess G, Lentine KL. Economic impacts of alternative kidney transplant immunosuppression: A national cohort study. Clin Transplant 2020;34. [DOI: 10.1111/ctr.13813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Yin S, Song T, Jiang Y, Li X, Fan Y, Lin T. Tacrolimus Trough Level at the First Month May Predict Renal Transplantation Outcomes Among Living Chinese Kidney Transplant Patients: A Propensity Score-Matched Analysis. Ther Drug Monit 2019;41:308-16. [PMID: 31083041 DOI: 10.1097/FTD.0000000000000593] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
130 Otsuka R, Wada H, Tsuji H, Sasaki A, Murata T, Itoh M, Baghdadi M, Seino KI. Efficient generation of thymic epithelium from induced pluripotent stem cells that prolongs allograft survival. Sci Rep 2020;10:224. [PMID: 31937817 DOI: 10.1038/s41598-019-57088-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
131 Maekawa YM, Horie K, Iinuma K, Takai M, Ohzawa K, Tsuchiya T, Kato D, Taniguchi T, Ito H, Hishida S, Nakane K, Mizutani K, Koie T, Kato T. Effect of Posttransplant Diabetes Mellitus on Graft Loss After Living-Donor Kidney Transplant at a Single Institution. Transplant Proc 2020;52:162-8. [PMID: 31901320 DOI: 10.1016/j.transproceed.2019.10.025] [Reference Citation Analysis]
132 Pressiat C, Barau C, Hulin A, Ghaleh B. Médicaments du rejet de greffe. Pharmacologie des Médicaments de la Douleur, des Pathologies Inflammatoires, Immunitaires et Rhumatismales et de L'anesthésie 2020. [DOI: 10.1016/b978-2-294-76697-8.00003-x] [Reference Citation Analysis]
133 Mathias CB, Mcaleer JP. Transplantation: Immunologic Principles and Pharmacologic Agents. Pharmacology of Immunotherapeutic Drugs 2020. [DOI: 10.1007/978-3-030-19922-7_8] [Reference Citation Analysis]
134 Boissier R, Territo A, Breda A. Immunology in Tumor and Transplant. Urologic Principles and Practice 2020. [DOI: 10.1007/978-3-030-28599-9_11] [Reference Citation Analysis]
135 Schlosser M, Foller S, Grimm M, Wolf G. Nierentransplantation. Elsevier Essentials Nephrologie 2020. [DOI: 10.1016/b978-3-437-21691-6.00011-6] [Reference Citation Analysis]
136 Eda H, Jahana M, Miyazato T. A case of severe <i>Legionella</i> pneumonia in the late stage after renal transplantation. Nihon Toseki Igakkai Zasshi 2020;53:487-492. [DOI: 10.4009/jsdt.53.487] [Reference Citation Analysis]
137 Xie Y, Lor KW, Kobashigawa JA. Immunosuppression in Cardiac Transplantation. Cardiac Surgery 2020. [DOI: 10.1007/978-3-030-24174-2_72] [Reference Citation Analysis]
138 Rivillas-reyes JF, Hernández-durán EF, Morales-manrique JL, Rivillas MP, Lozano-marquez E, Lozano-marquez H. Inducción de tolerancia por vía oral en trasplante de órganos y tejidos. Revisión de la Literatura. Rev Fac Med 2020;68. [DOI: 10.15446/revfacmed.v68n1.72108] [Reference Citation Analysis]
139 Sun L, Fainstad T, Knight C. Anti-rejection Medication Therapy in the Adult Solid Organ Transplant Recipient. Primary Care of the Solid Organ Transplant Recipient 2020. [DOI: 10.1007/978-3-030-50629-2_3] [Reference Citation Analysis]
140 Samson M, Greigert H, Ghesquiere T, Bonnotte B. Artérite à cellules géantes : de la physiopathologie aux nouvelles cibles thérapeutiques. Bulletin de l'Académie Nationale de Médecine 2020;204:18-28. [DOI: 10.1016/j.banm.2019.10.016] [Reference Citation Analysis]
141 Kitamura M, Mochizuki Y, Matsuda T, Mukae Y, Nakanishi H, Ota Y, Uramatsu T, Obata Y, Sakai H, Mukae H, Nishino T. Sex differences in uric acid levels in kidney transplant recipients and their donors: a preliminary retrospective cross-sectional study. Ren Replace Ther 2019;5:47. [DOI: 10.1186/s41100-019-0242-7] [Reference Citation Analysis]
142 Engels EA. Epidemiologic perspectives on immunosuppressed populations and the immunosurveillance and immunocontainment of cancer. Am J Transplant 2019;19:3223-32. [PMID: 31206226 DOI: 10.1111/ajt.15495] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
143 Uehara M, Bahmani B, Jiang L, Jung S, Banouni N, Kasinath V, Solhjou Z, Zhao J, Ordikhani F, Bae M, Annabi N, McGrath MM, Abdi R. Nanodelivery of Mycophenolate Mofetil to the Organ Improves Transplant Vasculopathy. ACS Nano 2019;13:12393-407. [PMID: 31518498 DOI: 10.1021/acsnano.9b05115] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
144 Lattimore S, Skill NJ, Maluccio MA, Elliott H, Dobben E, Shafuddin A, Goggins WC. Antithymocyte Globulin Antibody Titer Congruent With Kidney Transplantation: Analysis of Incidence, Outcomes, Cost, and Alternative Targets. Transplant Direct 2019;5:e493. [PMID: 31723588 DOI: 10.1097/TXD.0000000000000933] [Reference Citation Analysis]
145 Maeda N, Maruhashi T, Sugiura D, Shimizu K, Okazaki IM, Okazaki T. Glucocorticoids potentiate the inhibitory capacity of programmed cell death 1 by up-regulating its expression on T cells. J Biol Chem 2019;294:19896-906. [PMID: 31723031 DOI: 10.1074/jbc.RA119.010379] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
146 Ghareeb M, Gohh RY, Akhlaghi F. Tacrolimus Concentration in Saliva of Kidney Transplant Recipients: Factors Influencing the Relationship with Whole Blood Concentrations. Clin Pharmacokinet 2018;57:1199-210. [PMID: 29330784 DOI: 10.1007/s40262-017-0626-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
147 Banas MC, Neumann S, Pagel P, Putz FJ, Krämer BK, Böhmig GA, Eiglsperger J, Schiffer E, Ruemmele P, Banas B. A urinary metabolite constellation to detect acute rejection in kidney allografts. EBioMedicine 2019;48:505-12. [PMID: 31648995 DOI: 10.1016/j.ebiom.2019.10.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
148 Hultin S, M. Hawley C, W. Johnson D, S. Francis R. Perioperative Care for Kidney Transplant Recipients. Perioperative Care for Organ Transplant Recipient 2019. [DOI: 10.5772/intechopen.84388] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
149 Tatapudi VS, Montgomery RA. Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads. Front Immunol 2019;10:2306. [PMID: 31632397 DOI: 10.3389/fimmu.2019.02306] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
150 Yakubu I, Ravichandran B, Sparkes T, Barth RN, Haririan A, Masters B. Comparison of Alemtuzumab Versus Basiliximab Induction Therapy in Elderly Kidney Transplant Recipients: A Single-Center Experience. J Pharm Pract 2021;34:199-206. [PMID: 31315501 DOI: 10.1177/0897190019850934] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
151 Sugünes N, Bichmann A, Biernath N, Peters R, Budde K, Liefeldt L, Schlomm T, Friedersdorff F. Analysis of the Effects of Day-Time vs. Night-Time Surgery on Renal Transplant Patient Outcomes. J Clin Med 2019;8:E1051. [PMID: 31323849 DOI: 10.3390/jcm8071051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
152 Abdollahi S, Boktor J, Hibino N. Bioprinting of freestanding vascular grafts and the regulatory considerations for additively manufactured vascular prostheses. Transl Res 2019;211:123-38. [PMID: 31201778 DOI: 10.1016/j.trsl.2019.05.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
153 Ward A, Klassen DK, Franz KM, Giwa S, Lewis JK. Social, economic, and policy implications of organ preservation advances. Curr Opin Organ Transplant 2018;23:336-46. [PMID: 29683801 DOI: 10.1097/MOT.0000000000000532] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
154 Buxeda A, Redondo-Pachón D, Pérez-Sáez MJ, Bartolomé Á, Mir M, Pascual-Dapena A, Sans A, Duran X, Crespo M, Pascual J. Gender differences in cancer risk after kidney transplantation. Oncotarget 2019;10:3114-28. [PMID: 31139324 DOI: 10.18632/oncotarget.26859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
155 Spasić A, Catić-Đorđević A, Veličković-Radovanović R, Stefanović N, Džodić P, Cvetković T. Adverse effects of mycophenolic acid in renal transplant recipients: gender differences. Int J Clin Pharm 2019;41:776-84. [PMID: 31028595 DOI: 10.1007/s11096-019-00837-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
156 Ho CM, Chen HL, Hu RH, Lee PH. Harnessing immunotherapy for liver recipients with hepatocellular carcinoma: a review from a transplant oncology perspective. Ther Adv Med Oncol 2019;11:1758835919843463. [PMID: 31065295 DOI: 10.1177/1758835919843463] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
157 Zarca K, Durand-Zaleski I, Loriot MA, Chatellier G, Pallet N. Modeling the Outcome of Systematic TPMT Genotyping or Phenotyping Before Azathioprine Prescription: A Cost-Effectiveness Analysis. Mol Diagn Ther 2019;23:429-38. [PMID: 30963516 DOI: 10.1007/s40291-019-00398-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
158 Zeng Q, Qiu F, Chen Y, Liu C, Liu H, Liang CL, Zhang Q, Dai Z. Shikonin Prolongs Allograft Survival via Induction of CD4+FoxP3+ Regulatory T Cells. Front Immunol 2019;10:652. [PMID: 30988670 DOI: 10.3389/fimmu.2019.00652] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
159 Theile D, Cho WC. Pharmacodynamic monitoring using biomarkers to individualize pharmacotherapy. Biomarkers in Medicine 2019;13:393-408. [DOI: 10.2217/bmm-2018-0355] [Reference Citation Analysis]
160 Garnier AS, Planchais M, Riou J, Jacquemin C, Ordonez L, Saint-André JP, Croue A, Saoudi A, Delneste Y, Devys A, Boutin I, Subra JF, Duveau A, Augusto JF. Pre-transplant CD45RC expression on blood T cells differentiates patients with cancer and rejection after kidney transplantation. PLoS One 2019;14:e0214321. [PMID: 30925186 DOI: 10.1371/journal.pone.0214321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
161 Pradier A, Papaserafeim M, Li N, Rietveld A, Kaestel C, Gruaz L, Vonarburg C, Spirig R, Puga Yung GL, Seebach JD. Small-Molecule Immunosuppressive Drugs and Therapeutic Immunoglobulins Differentially Inhibit NK Cell Effector Functions in vitro. Front Immunol 2019;10:556. [PMID: 30972058 DOI: 10.3389/fimmu.2019.00556] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
162 Krakauer T. Staphylococcal Superantigens: Pyrogenic Toxins Induce Toxic Shock. Toxins (Basel) 2019;11:E178. [PMID: 30909619 DOI: 10.3390/toxins11030178] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 11.8] [Reference Citation Analysis]
163 Fuehner T, Benden C, Gottlieb J. Initial immunosuppression and managing rejection. Intensive Care Med 2019;45:388-90. [PMID: 30877321 DOI: 10.1007/s00134-018-05515-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
164 Mansell H, Rosaasen N, West-Thielke P, Wichart J, Daley C, Mainra R, Shoker A, Liu J, Blackburn D. Randomised controlled trial of a video intervention and behaviour contract to improve medication adherence after renal transplantation: the VECTOR study protocol. BMJ Open 2019;9:e025495. [PMID: 30872550 DOI: 10.1136/bmjopen-2018-025495] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
165 Doh KC, Kim BM, Kim KW, Chung BH, Yang CW. Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression. BMC Complement Altern Med 2019;19:54. [PMID: 30832648 DOI: 10.1186/s12906-019-2464-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
166 Murad N, Tran H, Banks H. Optimal control of immunosuppressants in renal transplant recipients susceptible to BKV infection. Optim Control Appl Meth 2019;40:292-309. [DOI: 10.1002/oca.2478] [Reference Citation Analysis]
167 Li M, Mittal SK, Foulsham W, Amouzegar A, Sahu SK, Chauhan SK. Mast cells contribute to the induction of ocular mucosal alloimmunity. Am J Transplant 2019;19:662-73. [PMID: 30129280 DOI: 10.1111/ajt.15084] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
168 Liu H, Qiu F, Wang Y, Zeng Q, Liu C, Chen Y, Liang CL, Zhang Q, Han L, Dai Z. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival. Front Immunol 2019;10:306. [PMID: 30863408 DOI: 10.3389/fimmu.2019.00306] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
169 Berge LAM, Andreassen BK, Stenehjem JS, Larsen IK, Furu K, Juzeniene A, Roscher I, Heir T, Green A, Veierød MB, Robsahm TE. Cardiovascular, antidepressant and immunosuppressive drug use in relation to risk of cutaneous melanoma: a protocol for a prospective case-control study. BMJ Open 2019;9:e025246. [PMID: 30787091 DOI: 10.1136/bmjopen-2018-025246] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
170 Rovira J, Ramírez-Bajo MJ, Banon-Maneus E, Lazo-Rodríguez M, Moya-Rull D, Hierro-Garcia N, Tubita V, Piñeiro GJ, Revuelta I, Ventura-Aguiar P, Cucchiari D, Oppenheimer F, Brunet M, Campistol JM, Diekmann F. Tofacitinib Halts Progression of Graft Dysfunction in a Rat Model of Mixed Cellular and Humoral Rejection. Transplantation 2018;102:1075-84. [PMID: 29620612 DOI: 10.1097/TP.0000000000002204] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
171 Bahmani B, Vohra I, Kamaly N, Abdi R. Active targeted delivery of immune therapeutics to lymph nodes. Curr Opin Organ Transplant 2018;23:8-14. [PMID: 29176361 DOI: 10.1097/MOT.0000000000000495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
172 Philley JV, Safdar A, Daley CL. Nontuberculous Mycobacterial Disease in Transplant Recipients. Principles and Practice of Transplant Infectious Diseases 2019. [DOI: 10.1007/978-1-4939-9034-4_30] [Reference Citation Analysis]
173 Bodge M, Cumpston A. Pharmacology of Drugs Used in Hematopoietic Cell Transplantation. Hematopoietic Cell Transplantation for Malignant Conditions 2019. [DOI: 10.1016/b978-0-323-56802-9.00002-x] [Reference Citation Analysis]
174 Bae E, Han SS, Park DJ, Lee H, Yu M, Kim KH, Kim MC, Cho J, Min S, Ha J, Kim YS, Yang SH. The level of intracellular tacrolimus in T cell is affected by CD44+ABCB1+activities triggered by inflammation. Eur J Inflamm 2019;17:205873921984515. [DOI: 10.1177/2058739219845155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
175 Tönshoff B. Immunosuppressants in Organ Transplantation. Handb Exp Pharmacol 2020;261:441-69. [PMID: 31820175 DOI: 10.1007/164_2019_331] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
176 Pilch NA, Meadows HB, Alloway RR. Monoclonal Antibodies in Solid Organ Transplantation. Pharmaceutical Biotechnology 2019. [DOI: 10.1007/978-3-030-00710-2_25] [Reference Citation Analysis]
177 Thomas B, Weir MR. Immunosuppression. Nephrology Secrets 2019. [DOI: 10.1016/b978-0-323-47871-7.00066-6] [Reference Citation Analysis]
178 Wang D, Meiser B, Eisen HJ, Eifert S. Immunosuppression, Including Drug Toxicity, Interactions, New Immunosuppressants in the Pipeline. Heart Failure 2019. [DOI: 10.1007/978-3-319-98184-0_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
179 Freeman AF, Cuellar-rodriguez JM. Infections in the Immunocompromised Host. Clinical Immunology 2019. [DOI: 10.1016/b978-0-7020-6896-6.00037-5] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Pelletier JH, David EE, Chua AN, Chambers ET. Acute and Chronic Kidney Transplant Rejection in Adolescents: Causes and Treatment. Adolescents with Chronic Kidney Disease 2019. [DOI: 10.1007/978-3-319-97220-6_15] [Reference Citation Analysis]
181 Lee B, Park E, Ha J, Ha IS, Il Cheong H, Kang HG. Disseminated adenovirus infection in a 10-year-old renal allograft recipient. Kidney Res Clin Pract 2018;37:414-7. [PMID: 30619697 DOI: 10.23876/j.krcp.18.0048] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
182 Panahi Y, Mojtahedzadeh M, Najafi A, Rajaee SM, Torkaman M, Sahebkar A. Neuroprotective Agents in the Intensive Care Unit: -Neuroprotective Agents in ICU. J Pharmacopuncture 2018;21:226-40. [PMID: 30652049 DOI: 10.3831/KPI.2018.21.026] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
183 Saini A, Breen I, Alzubaidi S, Pershad Y, Sheth R, Naidu S, Knuttinen MG, Albadawi H, Oklu R. Irreversible Electroporation in Liver Cancers and Whole Organ Engineering. J Clin Med 2018;8:E22. [PMID: 30585195 DOI: 10.3390/jcm8010022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
184 Bak S, Tischer S, Dragon A, Ravens S, Pape L, Koenecke C, Oelke M, Blasczyk R, Maecker-Kolhoff B, Eiz-Vesper B. Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression. Front Immunol 2018;9:2953. [PMID: 30619313 DOI: 10.3389/fimmu.2018.02953] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
185 Machado FP, Vicari AR, Spuldaro F, Castro Filho JBS, Manfro RC. Polyclonal anti T-lymphocyte antibody therapy monitoring in kidney transplant recipients: comparison of CD3+ T cell and total lymphocyte counts. Einstein (Sao Paulo) 2018;16:eAO4278. [PMID: 30517367 DOI: 10.31744/einstein_journal/2018AO4278] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
186 Bahmani B, Uehara M, Jiang L, Ordikhani F, Banouni N, Ichimura T, Solhjou Z, Furtmüller GJ, Brandacher G, Alvarez D, von Andrian UH, Uchimura K, Xu Q, Vohra I, Yilmam OA, Haik Y, Azzi J, Kasinath V, Bromberg JS, McGrath MM, Abdi R. Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival. J Clin Invest 2018;128:4770-86. [PMID: 30277476 DOI: 10.1172/JCI120923] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 8.6] [Reference Citation Analysis]
187 Knight SR, Alasadi A, Clancy M. The immunology of solid organ transplantation. Anaesthesia & Intensive Care Medicine 2018;19:579-82. [DOI: 10.1016/j.mpaic.2018.08.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
188 Huo Q, Zhou M, Cooper DKC, Dai Y, Xie N, Mou L. Circulating miRNA or circulating DNA-Potential biomarkers for organ transplant rejection. Xenotransplantation 2019;26:e12444. [DOI: 10.1111/xen.12444] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
189 Cajanding R. Immunosuppression following organ transplantation. Part 1: mechanisms and immunosuppressive agents. Br J Nurs 2018;27:920-7. [PMID: 30187798 DOI: 10.12968/bjon.2018.27.16.920] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
190 Borges TJ, Murakami N, Machado FD, Murshid A, Lang BJ, Lopes RL, Bellan LM, Uehara M, Antunes KH, Pérez-Saéz MJ, Birrane G, Vianna P, Gonçalves JIB, Zanin RF, Azzi J, Abdi R, Ishido S, Shin JS, Souza APD, Calderwood SK, Riella LV, Bonorino C. March1-dependent modulation of donor MHC II on CD103+ dendritic cells mitigates alloimmunity. Nat Commun 2018;9:3482. [PMID: 30154416 DOI: 10.1038/s41467-018-05572-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
191 Gharagozloo M, Mahmoud S, Simard C, Mahvelati TM, Amrani A, Gris D. The Dual Immunoregulatory function of Nlrp12 in T Cell-Mediated Immune Response: Lessons from Experimental Autoimmune Encephalomyelitis. Cells 2018;7:E119. [PMID: 30150571 DOI: 10.3390/cells7090119] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
192 Shaban E, Bayliss G, Malhotra DK, Shemin D, Wang LJ, Gohh R, Dworkin LD, Gong R. Targeting Regulatory T Cells for Transplant Tolerance: New Insights and Future Perspectives. Kidney Dis (Basel) 2018;4:205-13. [PMID: 30574497 DOI: 10.1159/000490703] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
193 Andrade-sierra J, Vazquez-galvan PA, Hernandez-reyes H, Mercado-jáuregui LA, Chávez-iñiguez JS, González-espinoza E, Gómez-navarro B, Cerrillos-gutiérrez JI. Immunosuppressive Minimization Strategies in Kidney Transplantation. Organ Donation and Transplantation - Current Status and Future Challenges 2018. [DOI: 10.5772/intechopen.77292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
194 Cortazar FB, Rosenthal J, Laliberte K, Niles JL. Continuous B-cell depletion in frequently relapsing, steroid-dependent and steroid-resistant nephrotic syndrome. Clin Kidney J 2019;12:224-31. [PMID: 30976400 DOI: 10.1093/ckj/sfy067] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
195 Weber S, Dienemann T, Jacobi J, Eckardt KU, Weidemann A. Delayed graft function is associated with an increased rate of renal allograft rejection: A retrospective single center analysis. PLoS One 2018;13:e0199445. [PMID: 29928026 DOI: 10.1371/journal.pone.0199445] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
196 Peters FS, Peeters AMA, Mandaviya PR, van Meurs JBJ, Hofland LJ, van de Wetering J, Betjes MGH, Baan CC, Boer K. Differentially methylated regions in T cells identify kidney transplant patients at risk for de novo skin cancer. Clin Epigenetics 2018;10:81. [PMID: 29946375 DOI: 10.1186/s13148-018-0519-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
197 Chung BH, Yang CW, Cho ML. Clinical significance of Th17 cells in kidney transplantation. Korean J Intern Med 2018;33:860-6. [PMID: 29843491 DOI: 10.3904/kjim.2018.095] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
198 van Sandwijk MS, de Vries APJ, Bakker SJL, Ten Berge IJM, Berger SP, Bouatou YR, de Fijter JW, Florquin S, Homan van der Heide JJ, Idu MM, Krikke C, van der Pant KAMI, Reinders ME, Ringers J, van der Weerd NC, Bemelman FJ, Sanders JS. Early Steroid Withdrawal Compared With Standard Immunosuppression in Kidney Transplantation - Interim Analysis of the Amsterdam-Leiden-Groningen Randomized Controlled Trial. Transplant Direct. 2018;4:e354. [PMID: 30123827 DOI: 10.1097/txd.0000000000000794] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
199 Halawa A. Steroid withdrawal protocols in Renal Transplantation. Arch Clin Nephrol 2018. [DOI: 10.17352/acn.000029] [Reference Citation Analysis]
200 Fernández-Ramos AA, Marchetti-Laurent C, Poindessous V, Antonio S, Laurent-Puig P, Bortoli S, Loriot MA, Pallet N. 6-mercaptopurine promotes energetic failure in proliferating T cells. Oncotarget 2017;8:43048-60. [PMID: 28574837 DOI: 10.18632/oncotarget.17889] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
201 Yamamoto T, Iwase H, King TW, Hara H, Cooper DKC. Skin xenotransplantation: Historical review and clinical potential. Burns 2018;44:1738-49. [PMID: 29602717 DOI: 10.1016/j.burns.2018.02.029] [Cited by in Crossref: 43] [Cited by in F6Publishing: 34] [Article Influence: 8.6] [Reference Citation Analysis]
202 Snowsill TM, Moore J, Mujica Mota RE, Peters JL, Jones-Hughes TL, Huxley NJ, Coelho HF, Haasova M, Cooper C, Lowe JA, Varley-Campbell JL, Crathorne L, Allwood MJ, Anderson R. Immunosuppressive agents in adult kidney transplantation in the National Health Service: a model-based economic evaluation. Nephrol Dial Transplant 2017;32:1251-9. [PMID: 28873970 DOI: 10.1093/ndt/gfx074] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
203 Ryu G, Seo MY, Lee KE, Kim HY, Dhong HJ, Chung SK, Hong SD. Clinical course of rhinosinusitis and efficacy of sinonasal evaluation in kidney transplant recipients: review of 1589 patients. Eur Arch Otorhinolaryngol 2018;275:1183-8. [PMID: 29560507 DOI: 10.1007/s00405-018-4941-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
204 Ponnammal P, Kanaujia P, Yani Y, Ng WK, Tan RBH. Orally Disintegrating Tablets Containing Melt Extruded Amorphous Solid Dispersion of Tacrolimus for Dissolution Enhancement. Pharmaceutics 2018;10:E35. [PMID: 29547585 DOI: 10.3390/pharmaceutics10010035] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
205 Kaundal U, Bagai U, Rakha A. Immunomodulatory plasticity of mesenchymal stem cells: a potential key to successful solid organ transplantation. J Transl Med 2018;16:31. [PMID: 29448956 DOI: 10.1186/s12967-018-1403-0] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 8.2] [Reference Citation Analysis]
206 Hidalgo San Jose L, Stephens P, Song B, Barrow D. Microfluidic Encapsulation Supports Stem Cell Viability, Proliferation, and Neuronal Differentiation. Tissue Eng Part C Methods 2018;24:158-70. [PMID: 29258387 DOI: 10.1089/ten.TEC.2017.0368] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
207 Tatapudi VS, Lonze BE, Wu M, Montgomery RA. Early Conversion from Tacrolimus to Belatacept in a Highly Sensitized Renal Allograft Recipient with Calcineurin Inhibitor-Induced de novo Post-Transplant Hemolytic Uremic Syndrome. Case Rep Nephrol Dial 2018;8:10-9. [PMID: 29594146 DOI: 10.1159/000486158] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
208 Hawkinson DJ, Ison MG. Respiratory Viruses: Influenza, RSV, and Adenovirus in Kidney Transplantation. Semin Nephrol 2016;36:417-27. [PMID: 27772626 DOI: 10.1016/j.semnephrol.2016.05.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
209 Pallet N, Fernández-ramos AA, Loriot M. Impact of Immunosuppressive Drugs on the Metabolism of T Cells. International Review of Cell and Molecular Biology 2018. [DOI: 10.1016/bs.ircmb.2018.05.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
210 Koomalsingh K, Kobashigawa JA. The future of cardiac transplantation. Ann Cardiothorac Surg 2018;7:135-42. [PMID: 29492391 DOI: 10.21037/acs.2017.12.02] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
211 Hadamitzky M, Sondermann W, Benson S, Schedlowski M. Placebo Effects in the Immune System. International Review of Neurobiology 2018. [DOI: 10.1016/bs.irn.2018.01.001] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
212 Newland DM, Nemeth TL. Induction and Standard Immunosuppression. Solid Organ Transplantation in Infants and Children 2018. [DOI: 10.1007/978-3-319-07284-5_45] [Reference Citation Analysis]
213 Tamayo-enríquez G, Borja-cacho D. Hematologic Challenges in Intensive Care Unit Patients with Solid Organ Transplants. Hematologic Challenges in the Critically Ill 2018. [DOI: 10.1007/978-3-319-93572-0_14] [Reference Citation Analysis]
214 Lion J, Burbach M, Cross A, Poussin K, Taflin C, Kaveri S, Haziot A, Glotz D, Mooney N. Endothelial Cell Amplification of Regulatory T Cells Is Differentially Modified by Immunosuppressors and Intravenous Immunoglobulin. Front Immunol. 2017;8:1761. [PMID: 29312302 DOI: 10.3389/fimmu.2017.01761] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
215 Yanik EL, Shiels MS, Smith JM, Clarke CA, Lynch CF, Kahn AR, Koch L, Pawlish KS, Engels EA. Contribution of solid organ transplant recipients to the pediatric non-hodgkin lymphoma burden in the United States. Cancer 2017;123:4663-71. [PMID: 28759103 DOI: 10.1002/cncr.30923] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
216 Jia Y, Peng B, Li L, Wang J, Wang X, Qi G, Rong R, Wang L, Qiu J, Xu M, Zhu T. Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium. Ther Drug Monit 2017;39:29-36. [PMID: 27941535 DOI: 10.1097/FTD.0000000000000360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
217 Kannegieter NM, Hesselink DA, Dieterich M, de Graav GN, Kraaijeveld R, Baan CC. Differential T Cell Signaling Pathway Activation by Tacrolimus and Belatacept after Kidney Transplantation: Post Hoc Analysis of a Randomised-Controlled Trial. Sci Rep 2017;7:15135. [PMID: 29123208 DOI: 10.1038/s41598-017-15542-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
218 Baiocco JA, Metwalli AR. Multiplex Partial Nephrectomy, Repeat Partial Nephrectomy, and Salvage Partial Nephrectomy Remain the Primary Treatment in Multifocal and Hereditary Kidney Cancer. Front Oncol 2017;7:244. [PMID: 29104862 DOI: 10.3389/fonc.2017.00244] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
219 Dharnidharka VR, Naik AS, Axelrod DA, Schnitzler MA, Zhang Z, Bae S, Segev DL, Brennan DC, Alhamad T, Ouseph R, Lam NN, Nazzal M, Randall H, Kasiske BL, McAdams-Demarco M, Lentine KL. Center practice drives variation in choice of US kidney transplant induction therapy: a retrospective analysis of contemporary practice. Transpl Int 2018;31:198-211. [PMID: 28987015 DOI: 10.1111/tri.13079] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 6.5] [Reference Citation Analysis]
220 Rubín Suárez A, Bilbao Aguirre I, Fernández-castroagudin J, Pons Miñano JA, Salcedo Plaza M, Varo Pérez E, Prieto Castillo M. Recommendations of everolimus use in liver transplant. Gastroenterología y Hepatología (English Edition) 2017;40:629-640. [DOI: 10.1016/j.gastre.2017.10.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
221 Leal R, Tsapepas D, Crew RJ, Dube GK, Ratner L, Batal I. Pathology of Calcineurin and Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation. Kidney Int Rep 2018;3:281-90. [PMID: 30276344 DOI: 10.1016/j.ekir.2017.10.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
222 Sprangers B, Nair V, Launay-Vacher V, Riella LV, Jhaveri KD. Risk factors associated with post-kidney transplant malignancies: an article from the Cancer-Kidney International Network. Clin Kidney J. 2018;11:315-329. [PMID: 29942495 DOI: 10.1093/ckj/sfx122] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 11.5] [Reference Citation Analysis]
223 Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V. Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer. F1000Res 2017;6:1832. [PMID: 29225777 DOI: 10.12688/f1000research.12775.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
224 Fung AWS, Knauer MJ, Blasutig IM, Colantonio DA, Kulasingam V. Evaluation of electrochemiluminescence immunoassays for immunosuppressive drugs on the Roche cobas e411 analyzer. F1000Res 2017;6:1832. [PMID: 29225777 DOI: 10.12688/f1000research.12775.2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
225 Samy KP, Butler JR, Li P, Cooper DKC, Ekser B. The Role of Costimulation Blockade in Solid Organ and Islet Xenotransplantation. J Immunol Res 2017;2017:8415205. [PMID: 29159187 DOI: 10.1155/2017/8415205] [Cited by in Crossref: 31] [Cited by in F6Publishing: 38] [Article Influence: 5.2] [Reference Citation Analysis]
226 Gunawansa N. Tailor-Made Induction Therapy in ‘Low Risk’ Renal Transplants; A South Asian Perspective. Arch Clin Nephrol 2017. [DOI: 10.17352/acn.000024] [Reference Citation Analysis]
227 Fernández-Ramos AA, Marchetti-Laurent C, Poindessous V, Antonio S, Petitgas C, Ceballos-Picot I, Laurent-Puig P, Bortoli S, Loriot MA, Pallet N. A comprehensive characterization of the impact of mycophenolic acid on the metabolism of Jurkat T cells. Sci Rep 2017;7:10550. [PMID: 28874730 DOI: 10.1038/s41598-017-10338-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
228 Su J, He J, Su Z, Zhou L, Zeng Y, Lai X, Li Y. T cell inhibition by pogostone from Pogostemon cablin (Blanco) Benth: In vitro and in vivo immunosuppressive analysis. Mol Med Rep 2017;16:4511-20. [PMID: 28791344 DOI: 10.3892/mmr.2017.7147] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
229 Rubín Suárez A, Bilbao Aguirre I, Fernández-Castroagudin J, Pons Miñano JA, Salcedo Plaza M, Varo Pérez E, Prieto Castillo M. Recommendations of everolimus use in liver transplant. Gastroenterol Hepatol 2017;40:629-40. [PMID: 28743539 DOI: 10.1016/j.gastrohep.2017.05.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
230 Dai J, Fang P, Saredy J, Xi H, Ramon C, Yang W, Choi ET, Ji Y, Mao W, Yang X, Wang H. Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation. J Hematol Oncol 2017;10:141. [PMID: 28738836 DOI: 10.1186/s13045-017-0504-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
231 Peters FS, Peeters AMA, Hofland LJ, Betjes MGH, Boer K, Baan CC. Interferon-Gamma DNA Methylation Is Affected by Mycophenolic Acid but Not by Tacrolimus after T-Cell Activation. Front Immunol 2017;8:822. [PMID: 28747916 DOI: 10.3389/fimmu.2017.00822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
232 Wang LW, Wang JL, Chen J, Chen JJ, Shen JW, Feng XX, Kubicek CP, Lin FC, Zhang CL, Chen FY. A Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells. Front Microbiol 2017;8:1251. [PMID: 28725220 DOI: 10.3389/fmicb.2017.01251] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
233 Würdinger M, Modrow S, Plentz A. Impact of Parvovirus B19 Viremia in Liver Transplanted Children on Anemia: A Retrospective Study. Viruses 2017;9:149. [DOI: 10.3390/v9060149] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
234 Gluba-Brzózka A, Franczyk B, Olszewski R, Banach M, Rysz J. Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases. Int J Mol Sci 2017;18:E1248. [PMID: 28604601 DOI: 10.3390/ijms18061248] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
235 Gupta C, Moudgil A. Renal transplantation in children: Current status and challenges. Apollo Medicine 2017;14:88-99. [DOI: 10.1016/j.apme.2017.02.009] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
236 De Simone P, Fagiuoli S, Cescon M, De Carlis L, Tisone G, Volpes R, Cillo U. Use of Everolimus in Liver Transplantation: Recommendations From a Working Group. Transplantation. 2017;101:239-251. [PMID: 27495768 DOI: 10.1097/tp.0000000000001438] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
237 Lenihan CR, Montez-Rath ME, Winkelmayer WC, Chang TI. Drug-Eluting Stents Versus Bare Metal Stents for Percutaneous Coronary Intervention in Kidney Transplant Recipients. Transplantation 2017;101:851-7. [PMID: 27517730 DOI: 10.1097/TP.0000000000001446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
238 Furukawa A, Wisel SA, Tang Q. Impact of Immune-Modulatory Drugs on Regulatory T Cell. Transplantation 2016;100:2288-300. [PMID: 27490409 DOI: 10.1097/TP.0000000000001379] [Cited by in Crossref: 73] [Cited by in F6Publishing: 77] [Article Influence: 12.2] [Reference Citation Analysis]
239 DiLoreto R, Khush K, De Vlaminck I. Precision monitoring of immunotherapies in solid organ and hematopoietic stem cell transplantation. Adv Drug Deliv Rev 2017;114:272-84. [PMID: 28625828 DOI: 10.1016/j.addr.2017.06.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
240 Chesnaye NC, van Stralen KJ, Bonthuis M, Harambat J, Groothoff JW, Jager KJ. Survival in children requiring chronic renal replacement therapy. Pediatr Nephrol 2018;33:585-94. [PMID: 28508132 DOI: 10.1007/s00467-017-3681-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 4.2] [Reference Citation Analysis]
241 Shang W, Feng Y, Li J, Wang X, Xie H, Feng G. Effect of Bicyclol Tablets on Drug Induced Liver Injuries after Kidney Transplantation. Open Med (Wars) 2017;12:62-9. [PMID: 28730164 DOI: 10.1515/med-2017-0012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
242 Krakauer T. FDA-approved immunosuppressants targeting staphylococcal superantigens: mechanisms and insights. Immunotargets Ther 2017;6:17-29. [PMID: 28497030 DOI: 10.2147/ITT.S125429] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
243 Salgado PC, Genvigir FD, Felipe CR, Tedesco-Silva H Jr, Medina-Pestana JO, Doi SQ, Hirata MH, Hirata RD. Association of the PPP3CA c.249G>A variant with clinical outcomes of tacrolimus-based therapy in kidney transplant recipients. Pharmgenomics Pers Med 2017;10:101-6. [PMID: 28435308 DOI: 10.2147/PGPM.S131390] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
244 Tutakhel OAZ, Moes AD, Valdez-Flores MA, Kortenoeven MLA, Vrie MVD, Jeleń S, Fenton RA, Zietse R, Hoenderop JGJ, Hoorn EJ, Hilbrands L, Bindels RJM. NaCl cotransporter abundance in urinary vesicles is increased by calcineurin inhibitors and predicts thiazide sensitivity. PLoS One 2017;12:e0176220. [PMID: 28430812 DOI: 10.1371/journal.pone.0176220] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
245 De Simone P, Carrai P, Coletti L, Ghinolfi D, Petruccelli S, Filipponi F. Modification of immunosuppressive therapy as risk factor for complications after liver transplantation. Best Pract Res Clin Gastroenterol 2017;31:199-209. [PMID: 28624108 DOI: 10.1016/j.bpg.2017.03.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.7] [Reference Citation Analysis]
246 Van Keer J, Derthoo D, Van Caenegem O, De Pauw M, Nellessen E, Duerinckx N, Droogne W, Vörös G, Meyns B, Belmans A, Janssens S, Van Cleemput J, Vanhaecke J. The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial. J Transplant 2017;2017:6347138. [PMID: 28316834 DOI: 10.1155/2017/6347138] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Suzuki Y, Kohno K, Doki K, Ohkohchi N, Homma M. Improved Open-Well Stability of Affinity Column-Mediated Immunoassay Reagent for Determining Blood Tacrolimus. Ther Drug Monit 2017;39:202-3. [PMID: 28282367 DOI: 10.1097/FTD.0000000000000374] [Reference Citation Analysis]
248 Rovira J, Diekmann F, Campistol JM, Ramírez-bajo MJ. Therapeutic application of extracellular vesicles in acute and chronic renal injury. Nefrología (English Edition) 2017;37:126-37. [DOI: 10.1016/j.nefroe.2017.03.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
249 da Silva MB, da Cunha FF, Terra FF, Camara NOS. Old game, new players: Linking classical theories to new trends in transplant immunology. World J Transplant 2017; 7(1): 1-25 [PMID: 28280691 DOI: 10.5500/wjt.v7.i1.1] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
250 El-Agroudy AE, Alarrayed SM, Al-Ghareeb SM, Farid E, Alhelow H, Abdulla S. Efficacy and safety of early tacrolimus conversion to sirolimus after kidney transplantation: Long-term results of a prospective randomized study. Indian J Nephrol 2017;27:28-36. [PMID: 28182044 DOI: 10.4103/0971-4065.176146] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
251 Yoo KD, Kim CT, Kim MH, Noh J, Kim G, Kim H, An JN, Park JY, Cho H, Kim KH, Kim H, Ryu DR, Kim DK, Lim CS, Kim YS, Lee JP. Superior outcomes of kidney transplantation compared with dialysis: An optimal matched analysis of a national population-based cohort study between 2005 and 2008 in Korea. Medicine (Baltimore) 2016;95:e4352. [PMID: 27537562 DOI: 10.1097/MD.0000000000004352] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
252 Ye L, Lee J, Xu L, Mohammed AU, Li W, Hale JS, Tan WG, Wu T, Davis CW, Ahmed R, Araki K. mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses. J Virol 2017;91:e01653-16. [PMID: 27974559 DOI: 10.1128/JVI.01653-16] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
253 Kannegieter NM, Hesselink DA, Dieterich M, Kraaijeveld R, Rowshani AT, Leenen PJ, Baan CC. The Effect of Tacrolimus and Mycophenolic Acid on CD14+ Monocyte Activation and Function. PLoS One 2017;12:e0170806. [PMID: 28122021 DOI: 10.1371/journal.pone.0170806] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 5.2] [Reference Citation Analysis]
254 Haller MC, Kammer M, Kainz A, Baer HJ, Heinze G, Oberbauer R. Steroid withdrawal after renal transplantation: a retrospective cohort study. BMC Med 2017;15:8. [PMID: 28077142 DOI: 10.1186/s12916-016-0772-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.2] [Reference Citation Analysis]
255 Karahan GE, Claas FH, Heidt S. B Cell Immunity in Solid Organ Transplantation. Front Immunol 2016;7:686. [PMID: 28119695 DOI: 10.3389/fimmu.2016.00686] [Cited by in Crossref: 21] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
256 Kobashigawa J. The Future of Heart Transplantation. Clinical Guide to Heart Transplantation 2017. [DOI: 10.1007/978-3-319-43773-6_18] [Reference Citation Analysis]
257 Carty F, English K. The Immune Response to the Allograft. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00018-7] [Reference Citation Analysis]
258 Shetty AA, Wertheim JA, Butt Z. Health-Related Quality of Life Outcomes After Kidney Transplantation. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00050-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
259 Newland DM, Nemeth TL. Induction and Standard Immunosuppression. Solid Organ Transplantation in Infants and Children 2017. [DOI: 10.1007/978-3-319-08049-9_45-1] [Reference Citation Analysis]
260 Tomotani DY, Bafi AT, Pacheco ES, de Sandes-Freitas TV, Viana LA, de Oliveira Pontes EP, Tamura N, Tedesco-Silva H Jr, Machado FR, Freitas FG. The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease. J Thorac Dis 2017;9:166-75. [PMID: 28203420 DOI: 10.21037/jtd.2017.01.09] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
261 Menon MC, Cravedi P, El Salem F. Acute Cellular Rejection. Kidney Transplantation, Bioengineering and Regeneration 2017. [DOI: 10.1016/b978-0-12-801734-0.00032-1] [Reference Citation Analysis]
262 Koenig A, Thaunat O. Lymphoid Neogenesis and Tertiary Lymphoid Organs in Transplanted Organs. Front Immunol 2016;7:646. [PMID: 28082981 DOI: 10.3389/fimmu.2016.00646] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
263 Haller MC, Kainz A, Baer H, Oberbauer R. Dialysis Vintage and Outcomes after Kidney Transplantation: A Retrospective Cohort Study. Clin J Am Soc Nephrol 2017;12:122-30. [PMID: 27895135 DOI: 10.2215/CJN.04120416] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 8.0] [Reference Citation Analysis]
264 Dizdar OS, Ersoy A, Aksoy S, Ozel Coskun BD, Yildiz A. Analysis of liver function test abnormalities in kidney transplant recipients: 7 year experience. Pak J Med Sci 2016;32:1330-5. [PMID: 28083020 DOI: 10.12669/pjms.326.10725] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
265 Ho CM, Lee PH, Cheng WT, Hu RH, Wu YM, Ho MC. Succinct guide to liver transplantation for medical students. Ann Med Surg (Lond) 2016;12:47-53. [PMID: 27895907 DOI: 10.1016/j.amsu.2016.11.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
266 Durrbach A, Pestana JM, Florman S, Del Carmen Rial M, Rostaing L, Kuypers D, Matas A, Wekerle T, Polinsky M, Meier-Kriesche HU, Munier S, Grinyó JM. Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study. Am J Transplant 2016;16:3192-201. [PMID: 27130868 DOI: 10.1111/ajt.13830] [Cited by in Crossref: 98] [Cited by in F6Publishing: 99] [Article Influence: 14.0] [Reference Citation Analysis]
267 Kleinclauss F, Frontczak A, Terrier N, Thuret R, Timsit MO. [Immunology and immunosuppression in kidney transplantation. ABO and HLA incompatible kidney transplantation]. Prog Urol 2016;26:977-92. [PMID: 27670824 DOI: 10.1016/j.purol.2016.08.015] [Reference Citation Analysis]
268 Lavillegrand J, Zafrani L, Venot M, Canet E, Bigé N. Complications infectieuses graves chez le transplanté rénal en réanimation. Méd Intensive Réa 2016. [DOI: 10.1007/s13546-016-1224-1] [Reference Citation Analysis]
269 van Veen KEB, Brouwer MC, van der Ende A, van de Beek D. Bacterial Meningitis in Patients using Immunosuppressive Medication: a Population-based Prospective Nationwide Study. J Neuroimmune Pharmacol 2017;12:213-8. [PMID: 27613024 DOI: 10.1007/s11481-016-9705-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
270 Ishiwata Y, Nagata M, Arai T, Makiishi M, Yoshikawa M, Takahashi H, Kohsaka H, Yasuhara M. Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study. Ther Drug Monit 2016;38:717-21. [PMID: 27559841 DOI: 10.1097/FTD.0000000000000335] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
271 Kopp Fernandes L, Hummel M, Knosalla C, Schönrath F. Therapieformen bei fortgeschrittener Herzinsuffizienz. Kardiologe 2016;10:249-260. [DOI: 10.1007/s12181-016-0063-7] [Reference Citation Analysis]
272 Young JS, Chen J, Miller ML, Vu V, Tian C, Moon JJ, Alegre ML, Sciammas R, Chong AS. Delayed Cytotoxic T Lymphocyte-Associated Protein 4-Immunoglobulin Treatment Reverses Ongoing Alloantibody Responses and Rescues Allografts From Acute Rejection. Am J Transplant 2016;16:2312-23. [PMID: 26928966 DOI: 10.1111/ajt.13761] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
273 Li Y, Chen D, Wang X, Tong J, Li K, Jing Y, Li G. The Effect of Traditional Chinese Formula Danchaiheji on the Differentiation of Regulatory Dendritic Cells. Evid Based Complement Alternat Med 2016;2016:9179470. [PMID: 27525028 DOI: 10.1155/2016/9179470] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
274 Guzera M, Szulc-Dąbrowska L, Cywińska A, Archer J, Winnicka A. In Vitro Influence of Mycophenolic Acid on Selected Parameters of Stimulated Peripheral Canine Lymphocytes. PLoS One 2016;11:e0154429. [PMID: 27138877 DOI: 10.1371/journal.pone.0154429] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
275 Yanik EL, Chinnakotla S, Gustafson SK, Snyder JJ, Israni AK, Segev DL, Engels EA. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma. Liver Transpl 2016;22:627-34. [PMID: 26784951 DOI: 10.1002/lt.24395] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 5.0] [Reference Citation Analysis]
276 Azzi J, Yin Q, Uehara M, Ohori S, Tang L, Cai K, Ichimura T, McGrath M, Maarouf O, Kefaloyianni E, Loughhead S, Petr J, Sun Q, Kwon M, Tullius S, von Andrian UH, Cheng J, Abdi R. Targeted Delivery of Immunomodulators to Lymph Nodes. Cell Rep 2016;15:1202-13. [PMID: 27134176 DOI: 10.1016/j.celrep.2016.04.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
277 Ghosh I, Rathi M. Mammalian target of rapamycin inhibitors: A paradigm shift in current immunosuppression protocols. Indian Journal of Transplantation 2016;10:33-39. [DOI: 10.1016/j.ijt.2016.05.001] [Reference Citation Analysis]
278 Merino D, San Segundo D, Medina JM, Rodrigo E, Asensio E, Irure J, Fernández-Fresnedo G, Arias MA, López-Hoyos M. Different in vitro proliferation and cytokine-production inhibition of memory T-cell subsets after calcineurin and mammalian target of rapamycin inhibitors treatment. Immunology 2016;148:206-15. [PMID: 26931075 DOI: 10.1111/imm.12603] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
279 McKee RA, Wingert RA. Repopulating Decellularized Kidney Scaffolds: An Avenue for Ex Vivo Organ Generation. Materials (Basel) 2016;9:190. [PMID: 27375844 DOI: 10.3390/ma9030190] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
280 Marinho KCT, Giovani EM. PDT in non-surgical treatment of periodontitis in kidney transplanted patients: a split-mouth, randomized clinical trial. SPIE Proceedings 2016. [DOI: 10.1117/12.2211770] [Reference Citation Analysis]
281 Ashraf MI, Schwelberger HG, Brendel KA, Feurle J, Andrassy J, Kotsch K, Regele H, Pratschke J, Maier HT, Aigner F. Exogenous Lipocalin 2 Ameliorates Acute Rejection in a Mouse Model of Renal Transplantation. Am J Transplant 2016;16:808-20. [PMID: 26595644 DOI: 10.1111/ajt.13521] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
282 Coghill AE, Johnson LG, Berg D, Resler AJ, Leca N, Madeleine MM. Immunosuppressive Medications and Squamous Cell Skin Carcinoma: Nested Case-Control Study Within the Skin Cancer after Organ Transplant (SCOT) Cohort. Am J Transplant 2016;16:565-73. [PMID: 26824445 DOI: 10.1111/ajt.13596] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 9.0] [Reference Citation Analysis]
283 Ascha MS, Ascha ML, Hanouneh IA. Management of immunosuppressant agents following liver transplantation: Less is more. World J Hepatol 2016; 8(3): 148-161 [PMID: 26839639 DOI: 10.4254/wjh.v8.i3.148] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
284 Linnik JE, Egli A. Impact of host genetic polymorphisms on vaccine induced antibody response. Hum Vaccin Immunother 2016;12:907-15. [PMID: 26809773 DOI: 10.1080/21645515.2015.1119345] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 4.9] [Reference Citation Analysis]
285 Witt LJ, Demchuk C, Curran JJ, Strek ME. Benefit of adjunctive tacrolimus in connective tissue disease-interstitial lung disease. Pulm Pharmacol Ther 2016;36:46-52. [PMID: 26762710 DOI: 10.1016/j.pupt.2015.12.004] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.9] [Reference Citation Analysis]
286 Thomas HE, Graham KL, Loudovaris T, Kay TWH. Regenerative Medicine: Clinical Islet Transplantation. Pancreatic Islet Biology 2016. [DOI: 10.1007/978-3-319-45307-1_11] [Reference Citation Analysis]
287 Vardanyan R, Hruby V. Immunopharmacological Drugs. Synthesis of Best-Seller Drugs 2016. [DOI: 10.1016/b978-0-12-411492-0.00029-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
288 Wieland E. Markers of lymphocyte activation and proliferation. Personalized Immunosuppression in Transplantation 2016. [DOI: 10.1016/b978-0-12-800885-0.00010-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
289 Offermanns S. Immunsuppressiva, Immunmodulatoren. Pharmakologie und Toxikologie 2016. [DOI: 10.1007/978-3-662-46689-6_25] [Reference Citation Analysis]
290 Kidd B, Dudley J. Systems Immunology. Translational Immunology 2016. [DOI: 10.1016/b978-0-12-801577-3.00001-0] [Reference Citation Analysis]
291 Baron D, Giral M, Brouard S. Biomarkers of tolerance in kidney transplantation. Personalized Immunosuppression in Transplantation 2016. [DOI: 10.1016/b978-0-12-800885-0.00008-4] [Reference Citation Analysis]
292 Boucher HW, Wiehe SM. Common Drug Interactions Encountered in Treating Transplant-Related Infection. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_4] [Reference Citation Analysis]
293 Sarabu N, Hricik DE. Introduction to Solid Organ Transplantation. Transplant Infections 2016. [DOI: 10.1007/978-3-319-28797-3_2] [Reference Citation Analysis]
294 Khan MM. Immunosuppressive Agents. Immunopharmacology 2016. [DOI: 10.1007/978-3-319-30273-7_4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
295 Pereira M, Gazzoni FF, Marchiori E, Irion K, Moreira J, Giacomelli IL, Pasqualotto A, Hochhegger B. High-resolution CT findings of pulmonary Mycobacterium tuberculosis infection in renal transplant recipients. Br J Radiol 2016;89:20150686. [PMID: 26607644 DOI: 10.1259/bjr.20150686] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
296 Chen JH, Wong G, Chapman JR, Lim WH. Cumulative Doses of T-Cell Depleting Antibody and Cancer Risk after Kidney Transplantation. PLoS One 2015;10:e0139479. [PMID: 26555791 DOI: 10.1371/journal.pone.0139479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
297 Couvrat-Desvergnes G, Salama A, Le Berre L, Evanno G, Viklicky O, Hruba P, Vesely P, Guerif P, Dejoie T, Rousse J, Nicot A, Bach JM, Ang E, Foucher Y, Brouard S, Castagnet S, Giral M, Harb J, Perreault H, Charreau B, Lorent M, Soulillou JP. Rabbit antithymocyte globulin-induced serum sickness disease and human kidney graft survival. J Clin Invest 2015;125:4655-65. [PMID: 26551683 DOI: 10.1172/JCI82267] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
298 Ng WY, Yeo CP. Clinical laboratory diagnostics of immunosuppressants: One laboratory’s journey. Proceedings of Singapore Healthcare 2015;24:219-24. [DOI: 10.1177/2010105815611807] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
299 Yap M, Brouard S, Pecqueur C, Degauque N. Targeting CD8 T-Cell Metabolism in Transplantation. Front Immunol 2015;6:547. [PMID: 26557123 DOI: 10.3389/fimmu.2015.00547] [Cited by in Crossref: 9] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
300 Scottà C, Fanelli G, Hoong SJ, Romano M, Lamperti EN, Sukthankar M, Guggino G, Fazekasova H, Ratnasothy K, Becker PD, Afzali B, Lechler RI, Lombardi G. Impact of immunosuppressive drugs on the therapeutic efficacy of ex vivo expanded human regulatory T cells. Haematologica 2016;101:91-100. [PMID: 26471483 DOI: 10.3324/haematol.2015.128934] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 5.9] [Reference Citation Analysis]
301 Lee HE, Yang G, Choi JS, Lee JY. Suppression of Primary Splenocyte Proliferation by Artemisia capillaris and Its Components. Toxicol Res 2017;33:283-90. [PMID: 29071012 DOI: 10.5487/TR.2017.33.4.283] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
302 Halloran PF, Kreepala C, Einecke G, Loupy A, Sellarés J. Therapeutic approaches to organ transplantation. Transplant Immunology 2015. [DOI: 10.1002/9781119072997.ch10] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
303 Carpenter WM, Cox DP. Kidney Disease. The ADA Practical Guide to Patients with Medical Conditions 2015. [DOI: 10.1002/9781119121039.ch5] [Reference Citation Analysis]
304 Chaumont M, Racapé J, Broeders N, El Mountahi F, Massart A, Baudoux T, Hougardy JM, Mikhalsky D, Hamade A, Le Moine A, Abramowicz D, Vereerstraeten P. Delayed Graft Function in Kidney Transplants: Time Evolution, Role of Acute Rejection, Risk Factors, and Impact on Patient and Graft Outcome. J Transplant 2015;2015:163757. [PMID: 26448870 DOI: 10.1155/2015/163757] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
305 Yanik EL, Siddiqui K, Engels EA. Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis. Cancer Med 2015;4:1448-59. [PMID: 26108799 DOI: 10.1002/cam4.487] [Cited by in Crossref: 72] [Cited by in F6Publishing: 75] [Article Influence: 9.0] [Reference Citation Analysis]
306 Jacobo-Cabral CO, García-Roca P, Romero-Tejeda EM, Reyes H, Medeiros M, Castañeda-Hernández G, Trocóniz IF. Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation. Br J Clin Pharmacol 2015;80:630-41. [PMID: 25846845 DOI: 10.1111/bcp.12649] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
307 Lee J, Lee JJ, Kim BS, Lee JG, Huh KH, Park Y, Kim YS. A 12-month single arm pilot study to evaluate the efficacy and safety of sirolimus in combination with tacrolimus in kidney transplant recipients at high immunologic risk. J Korean Med Sci 2015;30:682-7. [PMID: 26028917 DOI: 10.3346/jkms.2015.30.6.682] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
308 Zhang H, Guo H, Lu L, Zahorchak AF, Wiseman RW, Raimondi G, Cooper DK, Ezzelarab MB, Thomson AW. Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates. Am J Transplant 2015;15:1253-66. [PMID: 25783759 DOI: 10.1111/ajt.13113] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
309 Salazar ID, Merino López M, Chang J, Halloran PF. Reassessing the Significance of Intimal Arteritis in Kidney Transplant Biopsy Specimens. J Am Soc Nephrol 2015;26:3190-8. [PMID: 25918035 DOI: 10.1681/ASN.2014111064] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 5.3] [Reference Citation Analysis]
310 Sicard A, Koenig A, Morelon E, Defrance T, Thaunat O. Cell therapy to induce allograft tolerance: time to switch to plan B? Front Immunol 2015;6:149. [PMID: 25904913 DOI: 10.3389/fimmu.2015.00149] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
311 Želvys A, Vilimas J, Manikas M. Chirurginės komplikacijos po inkstų transplantacijos. Medicinos teorija ir praktika 2015;21:213-218. [DOI: 10.15591/mtp.2015.032] [Reference Citation Analysis]
312 Medeiros M, Castañeda-Hernández G, Ross CJ, Carleton BC. Use of pharmacogenomics in pediatric renal transplant recipients. Front Genet 2015;6:41. [PMID: 25741362 DOI: 10.3389/fgene.2015.00041] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
313 Nguyen le XT, Lee Y, Urbani L, Utz PJ, Hamburger AW, Sunwoo JB, Mitchell BS. Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1. Blood 2015;125:2519-29. [PMID: 25691158 DOI: 10.1182/blood-2014-12-616433] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
314 Kim KW, Chung BH, Kim BM, Cho ML, Yang CW. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology 2015;144:68-78. [PMID: 24974886 DOI: 10.1111/imm.12351] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 4.5] [Reference Citation Analysis]
315 Kaur S, Srivastava G, Sharma AN, Jolly RS. Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content. Br J Pharmacol 2015;172:2286-99. [PMID: 25537422 DOI: 10.1111/bph.13051] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
316 Cravedi P, Ruggenenti P, Remuzzi G. Successes and Disappointments with Clinical Islet Transplantation. Islets of Langerhans 2015. [DOI: 10.1007/978-94-007-6686-0_23] [Reference Citation Analysis]
317 Hooten JN, Myers SA. Update on Benign and Inflammatory Skin Disease Secondary to Transplant Medication. Advances in Transplant Dermatology 2015. [DOI: 10.1007/978-3-319-12445-2_1] [Reference Citation Analysis]
318 Bello A, Wiebe N, Garg A, Tonelli M. Evidence-based decision-making 2: Systematic reviews and meta-analysis. Methods Mol Biol 2015;1281:397-416. [PMID: 25694324 DOI: 10.1007/978-1-4939-2428-8_24] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
319 Dummer JS, Thomas LD. Risk Factors and Approaches to Infections in Transplant Recipients. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00311-8] [Reference Citation Analysis]
320 Popoola J, Greene H, Kyegombe M, MacPhee IA. Patient involvement in selection of immunosuppressive regimen following transplantation. Patient Prefer Adherence 2014;8:1705-12. [PMID: 25525347 DOI: 10.2147/PPA.S38987] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
321 Martin ST, Kato TS, Farr M, McKeen JT, Cheema F, Ji M, Ross A, Yerebakan H, Naka Y, Takayama H, Restaino S, Mancini D, Schulze PC. Similar survival in patients following heart transplantation receiving induction therapy using daclizumab vs. basiliximab. Circ J 2015;79:368-74. [PMID: 25501951 DOI: 10.1253/circj.CJ-14-0718] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
322 Dieterlen MT, Bittner HB, Tarnok A, Garbade J, Dhein S, Mohr FW, Barten MJ. Flow cytometric evaluation of T cell activation markers after cardiopulmonary bypass. Surg Res Pract 2014;2014:801643. [PMID: 25379560 DOI: 10.1155/2014/801643] [Reference Citation Analysis]
323 Halloran PF, Chang J, Famulski K, Hidalgo LG, Salazar ID, Merino Lopez M, Matas A, Picton M, de Freitas D, Bromberg J, Serón D, Sellarés J, Einecke G, Reeve J. Disappearance of T Cell-Mediated Rejection Despite Continued Antibody-Mediated Rejection in Late Kidney Transplant Recipients. J Am Soc Nephrol 2015;26:1711-20. [PMID: 25377077 DOI: 10.1681/ASN.2014060588] [Cited by in Crossref: 125] [Cited by in F6Publishing: 131] [Article Influence: 13.9] [Reference Citation Analysis]
324 Meijers RW, Betjes MG, Baan CC, Litjens NH. T-cell ageing in end-stage renal disease patients: Assessment and clinical relevance. World J Nephrol 2014; 3(4): 268-276 [PMID: 25374821 DOI: 10.5527/wjn.v3.i4.268] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 26] [Article Influence: 2.9] [Reference Citation Analysis]
325 Luxon BA. Potential catalysts in therapeutics. Liver Transpl 2014;20 Suppl 2:S22-31. [PMID: 25164576 DOI: 10.1002/lt.23971] [Reference Citation Analysis]
326 Kudo H, Wada H, Sasaki H, Tsuji H, Otsuka R, Baghdadi M, Kojo S, Chikaraishi T, Seino K. Induction of macrophage-like immunosuppressive cells from mouse ES cells that contribute to prolong allogeneic graft survival. PLoS One 2014;9:e111826. [PMID: 25356669 DOI: 10.1371/journal.pone.0111826] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
327 Singla AK, Gurram RK, Chauhan A, Khatri N, Vohra RM, Jolly RS, Agrewala JN. Caerulomycin A suppresses immunity by inhibiting T cell activity. PLoS One 2014;9:e107051. [PMID: 25286329 DOI: 10.1371/journal.pone.0107051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
328 Lin HY, Chang KT, Hung CC, Kuo CH, Hwang SJ, Chen HC, Hung CH, Lin SF. Effects of the mTOR inhibitor rapamycin on monocyte-secreted chemokines. BMC Immunol 2014;15:37. [PMID: 25257976 DOI: 10.1186/s12865-014-0037-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 4.0] [Reference Citation Analysis]
329 Shen J, Townsend R, You X, Shen Y, Zhan P, Zhou Z, Geng D, Wu D, McGirr N, Soucek K, Proszynski E, Pursley J, Masson E. Pharmacokinetics, pharmacodynamics, and immunogenicity of belatacept in adult kidney transplant recipients. Clin Drug Investig 2014;34:117-26. [PMID: 24217983 DOI: 10.1007/s40261-013-0153-2] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
330 Ganschow R, Pollok JM, Jankofsky M, Junge G. The role of everolimus in liver transplantation. Clin Exp Gastroenterol. 2014;7:329-343. [PMID: 25214801 DOI: 10.2147/ceg.s41780] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
331 Gallay B, Demattos A. Immunology of Transplant Protocols. Curr Otorhinolaryngol Rep 2014;2:184-191. [DOI: 10.1007/s40136-014-0057-6] [Reference Citation Analysis]
332 Sanclemente G, Moreno A, Navasa M, Lozano F, Cervera C. Genetic variants of innate immune receptors and infections after liver transplantation. World J Gastroenterol 2014; 20(32): 11116-11130 [PMID: 25170199 DOI: 10.3748/wjg.v20.i32.11116] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
333 Grafals M, Smith B, Murakami N, Trabucco A, Hamill K, Marangos E, Gilligan H, Pomfret EA, Pomposelli JJ, Simpson MA, Azzi J, Najafian N, Riella LV. Immunophenotyping and efficacy of low dose ATG in non-sensitized kidney recipients undergoing early steroid withdrawal: a randomized pilot study. PLoS One 2014;9:e104408. [PMID: 25111080 DOI: 10.1371/journal.pone.0104408] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
334 Grenda R. Biologics in renal transplantation. Pediatr Nephrol 2015;30:1087-98. [PMID: 25062963 DOI: 10.1007/s00467-014-2886-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
335 Nankivell BJ. Clinical Allograft Rejection Syndromes in Kidney Transplantation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch69] [Reference Citation Analysis]
336 Lees JR, Azimzadeh AM, Ding Y, Xu J, Bromberg JS. Current Pathways for Immune Manipulation. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch17] [Reference Citation Analysis]
337 Turnquist HR, Raimondi G, Metes D, Thomson AW. An Overview of Physiologic Immunity. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
338 Farris Iii AB, Mengel MH. Histopathological Syndromes of Kidney Allograft Rejection and Recurrent Disease. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch81] [Reference Citation Analysis]
339 Charafeddine AH, Kirk AD. Induction Immunosuppressive Therapy. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch65] [Reference Citation Analysis]
340 Ford ML, Adams AB, Larsen CP. The Spectrum of Alloimmunity, Heterologous Immunity, and Relevant Autoimmunity. Textbook of Organ Transplantation 2014. [DOI: 10.1002/9781118873434.ch9] [Reference Citation Analysis]
341 Ferguson BS, Hoggarth DA, Maliniak D, Ploense K, White RJ, Woodward N, Hsieh K, Bonham AJ, Eisenstein M, Kippin TE, Plaxco KW, Soh HT. Real-time, aptamer-based tracking of circulating therapeutic agents in living animals. Sci Transl Med 2013;5:213ra165. [PMID: 24285484 DOI: 10.1126/scitranslmed.3007095] [Cited by in Crossref: 217] [Cited by in F6Publishing: 217] [Article Influence: 24.1] [Reference Citation Analysis]
342 Prüfer J, Schuchardt M, Tölle M, Prüfer N, Höhne M, Zidek W, van der Giet M. Harmful effects of the azathioprine metabolite 6-mercaptopurine in vascular cells: induction of mineralization. PLoS One. 2014;9:e101709. [PMID: 25029363 DOI: 10.1371/journal.pone.0101709] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
343 Alex R, Mathew M, Arul S, Kundavaram A. Overdose of mycophenolate mofetil managed in a secondary care hospital in South India. Indian J Pharmacol 2014;46:337-8. [PMID: 24987184 DOI: 10.4103/0253-7613.132191] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
344 Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United States. Am J Hematol 2014;89:714-20. [PMID: 24753070 DOI: 10.1002/ajh.23726] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 3.7] [Reference Citation Analysis]
345 Meaney CJ, Arabi Z, Venuto RC, Consiglio JD, Wilding GE, Tornatore KM. Validity and reliability of a novel immunosuppressive adverse effects scoring system in renal transplant recipients. BMC Nephrol 2014;15:88. [PMID: 24925208 DOI: 10.1186/1471-2369-15-88] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
346 de Weerd A, Kho M, Kraaijeveld R, Zuiderwijk J, Weimar W, Baan C. The protein kinase C inhibitor sotrastaurin allows regulatory T cell function. Clin Exp Immunol 2014;175:296-304. [PMID: 24131367 DOI: 10.1111/cei.12225] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
347 Flechner SM, Mulgoankar S, Melton LB, Waid TH, Agarwal A, Miller SD, Fokta F, Getts MT, Frederick TJ, Herrman JJ, Puisis JP, O'Toole L, Sung R, Shihab F, Wiseman AC, Getts DR. First-in-human study of the safety and efficacy of TOL101 induction to prevent kidney transplant rejection. Am J Transplant 2014;14:1346-55. [PMID: 24751150 DOI: 10.1111/ajt.12698] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
348 Sereno J, Rodrigues-Santos P, Vala H, Rocha-Pereira P, Alves R, Fernandes J, Santos-Silva A, Carvalho E, Teixeira F, Reis F. Transition from cyclosporine-induced renal dysfunction to nephrotoxicity in an in vivo rat model. Int J Mol Sci 2014;15:8979-97. [PMID: 24853130 DOI: 10.3390/ijms15058979] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
349 Nandagopal N, Ali AK, Komal AK, Lee SH. The Critical Role of IL-15-PI3K-mTOR Pathway in Natural Killer Cell Effector Functions. Front Immunol 2014;5:187. [PMID: 24795729 DOI: 10.3389/fimmu.2014.00187] [Cited by in Crossref: 122] [Cited by in F6Publishing: 129] [Article Influence: 13.6] [Reference Citation Analysis]
350 Rosborough BR, Raïch-Regué D, Turnquist HR, Thomson AW. Regulatory myeloid cells in transplantation. Transplantation 2014;97:367-79. [PMID: 24092382 DOI: 10.1097/TP.0b013e3182a860de] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
351 Johnston CJ, McSorley HJ, Anderton SM, Wigmore SJ, Maizels RM. Helminths and immunological tolerance. Transplantation 2014;97:127-32. [PMID: 24025322 DOI: 10.1097/TP.0b013e3182a53f59] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
352 Vardhan H, Prasad N, Jaiswal A, Yadav B, Kumar S, Bhadauria D, Kaul A, Gupta A, Srivartava A, Sharma RK. Outcomes of living donor renal transplant recipients with and without basiliximab induction: A long-term follow-up study. Indian Journal of Transplantation 2014;8:44-50. [DOI: 10.1016/j.ijt.2014.06.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
353 Gala-Lopez B, Pepper AR, Shapiro AM. Biologic agents in islet transplantation. Curr Diab Rep. 2013;13:713-722. [PMID: 23918618 DOI: 10.1007/s11892-013-0414-8] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
354 Ogasawara K, Chitnis SD, Gohh RY, Christians U, Akhlaghi F. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients. Clin Pharmacokinet 2013;52:751-62. [PMID: 23633119 DOI: 10.1007/s40262-013-0069-2] [Cited by in Crossref: 61] [Cited by in F6Publishing: 63] [Article Influence: 6.8] [Reference Citation Analysis]
355 Zaza G, Rascio F, Pontrelli P, Granata S, Stifanelli P, Accetturo M, Ancona N, Gesualdo L, Lupo A, Grandaliano G. Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. BMC Med Genomics 2014;7:14. [PMID: 24625024 DOI: 10.1186/1755-8794-7-14] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
356 Krisl JC, Alloway RR, Shields AR, Cardi MA, Woodle ES. Bortezomib-based antibody-mediated rejection therapy and simultaneous conversion to belatacept. Transplantation 2014;97:e30-2. [PMID: 24531826 DOI: 10.1097/01.TP.0000441824.95510.97] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
357 Klintmalm GB, Nashan B. The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence. J Transplant. 2014;2014:845438. [PMID: 24719752 DOI: 10.1155/2014/845438] [Cited by in Crossref: 47] [Cited by in F6Publishing: 51] [Article Influence: 5.2] [Reference Citation Analysis]
358 Djamali A, Kaufman DB, Ellis TM, Zhong W, Matas A, Samaniego M. Diagnosis and management of antibody-mediated rejection: current status and novel approaches. Am J Transplant 2014;14:255-71. [PMID: 24401076 DOI: 10.1111/ajt.12589] [Cited by in Crossref: 266] [Cited by in F6Publishing: 266] [Article Influence: 29.6] [Reference Citation Analysis]
359 Carrion AF, Fabrizi F, Martin P. Liver Disease in Renal Transplant Recipients. Kidney Transplantation 2014. [DOI: 10.1007/978-1-4939-0342-9_23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
360 Chandran S, Vincenti FG. Immunosuppression in Transplantation. National Kidney Foundation Primer on Kidney Diseases 2014. [DOI: 10.1016/b978-1-4557-4617-0.00063-7] [Reference Citation Analysis]
361 廖 炯. Immunomodulation and Mechanism of Transplantation Immune Tolerance Induced by Glucocorticoids. IS 2014;02:5-10. [DOI: 10.12677/is.2014.21002] [Reference Citation Analysis]
362 Wood KJ, English K, Li O. Stem Cell-Based Approach to Immunomodulation. Regenerative Medicine Applications in Organ Transplantation 2014. [DOI: 10.1016/b978-0-12-398523-1.00061-6] [Reference Citation Analysis]
363 Macphee IAM. Immunosuppression for Kidney Transplantation. Practical Nephrology 2014. [DOI: 10.1007/978-1-4471-5547-8_70] [Reference Citation Analysis]
364 Zhang L, Roy A, Pfister M. Pharmacometrics in Chronic Kidney Disease. Applied Pharmacometrics 2014. [DOI: 10.1007/978-1-4939-1304-6_4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
365 Berry D, Feingold B. Immunosuppressive Medications. Pediatric and Congenital Cardiology, Cardiac Surgery and Intensive Care 2014. [DOI: 10.1007/978-1-4471-4619-3_133] [Reference Citation Analysis]
366 Zhang R, Paramesh A. Transplantation: Kidney, Kidney–Pancreas Transplant. Diabetes and Kidney Disease 2014. [DOI: 10.1007/978-1-4939-0793-9_15] [Reference Citation Analysis]
367 Cravedi P, Ruggenenti P, Remuzzi A, Remuzzi G. Current Status of Islet Transplantation. Regenerative Medicine Applications in Organ Transplantation 2014. [DOI: 10.1016/b978-0-12-398523-1.00040-9] [Reference Citation Analysis]
368 Barry JM. Renal Failure, Dialysis, and Transplantation in Older Adults. Geriatric Urology 2014. [DOI: 10.1007/978-1-4614-9047-0_21] [Reference Citation Analysis]
369 Kumbala D, Zhang R. Essential concept of transplant immunology for clinical practice. World J Transplant 2013; 3(4): 113-118 [PMID: 24392315 DOI: 10.5500/wjt.v3.i4.113] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
370 Verma M, Awdishu L, Lane J, Park K, Bahur B, Lwin W, McGee H, Steiner R, Finn P, Perkins D. Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity. J Surg Res 2014;188:309-15. [PMID: 24485875 DOI: 10.1016/j.jss.2013.11.1085] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
371 Xiong J, Xia M, Xu M, Zhang Y, Abais JM, Li G, Riebling CR, Ritter JK, Boini KM, Li PL. Autophagy maturation associated with CD38-mediated regulation of lysosome function in mouse glomerular podocytes. J Cell Mol Med 2013;17:1598-607. [PMID: 24238063 DOI: 10.1111/jcmm.12173] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
372 Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients. Hepatology 2013;58:1824-35. [PMID: 23532679 DOI: 10.1002/hep.26426] [Cited by in Crossref: 231] [Cited by in F6Publishing: 210] [Article Influence: 23.1] [Reference Citation Analysis]
373 Smethurst D. A pharmacologic perspective on newly emerging T-cell manipulation technologies. Br J Clin Pharmacol 2013;76:173-87. [PMID: 23039307 DOI: 10.1111/j.1365-2125.2012.04475.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
374 Bröcker V, Mengel M. Histopathological diagnosis of acute and chronic rejection in pediatric kidney transplantation. Pediatr Nephrol 2014;29:1939-49. [PMID: 24141526 DOI: 10.1007/s00467-013-2640-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
375 Maguire O, Tornatore KM, O'Loughlin KL, Venuto RC, Minderman H. Nuclear translocation of nuclear factor of activated T cells (NFAT) as a quantitative pharmacodynamic parameter for tacrolimus. Cytometry A 2013;83:1096-104. [PMID: 24136923 DOI: 10.1002/cyto.a.22401] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
376 Tan J, Wu YM, Ma B, Pang HL, Tian JH, Jiang L, Bai ZG, Li Y. FTY720 immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2013. [DOI: 10.1002/14651858.cd008010.pub2] [Reference Citation Analysis]
377 Khatri P, Roedder S, Kimura N, De Vusser K, Morgan AA, Gong Y, Fischbein MP, Robbins RC, Naesens M, Butte AJ. A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation. J Exp Med. 2013;210:2205-2221. [PMID: 24127489 DOI: 10.1084/jem.20122709] [Cited by in Crossref: 168] [Cited by in F6Publishing: 173] [Article Influence: 16.8] [Reference Citation Analysis]
378 Moten MA, Doligalski CT. Postoperative Transplant Immunosuppression in the Critical Care Unit. AACN Advanced Critical Care 2013;24:345-350. [DOI: 10.4037/nci.0b013e3182a23fb1] [Reference Citation Analysis]
379 Ro H, Min S, Jeong JC, Koo TY, Yang J, Ha J, Ahn C. The Impact of ABCB1 Gene Polymorphism on Steroid Responsiveness in Acute Rejection in Kidney Transplantation. Korean J Transplant 2013;27:107-113. [DOI: 10.4285/jkstn.2013.27.3.107] [Reference Citation Analysis]
380 Ge YZ, Wu R, Jia RP, Liu H, Yu P, Zhao Y, Feng YM. Association between interferon gamma +874 T>A polymorphism and acute renal allograft rejection: evidence from published studies. Mol Biol Rep 2013;40:6043-51. [PMID: 24057242 DOI: 10.1007/s11033-013-2714-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
381 Berglund D, Karlsson M, Biglarnia AR, Lorant T, Tufveson G, Korsgren O, Carlsson B. Obtaining regulatory T cells from uraemic patients awaiting kidney transplantation for use in clinical trials. Clin Exp Immunol 2013;173:310-22. [PMID: 23607776 DOI: 10.1111/cei.12112] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
382 Li Z, Zhang D, Gao J, Li WX, Zhu JY. Cyclosporine combined with nonlytic interleukin 2/Fc fusion protein improves immune response to hepatitis B vaccination in a mouse skin transplantation model. Transplant Proc 2013;45:2559-64. [PMID: 23953581 DOI: 10.1016/j.transproceed.2013.02.123] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
383 Varol U, Toprak O. Filtering lymphocytes may decrease the need for immunosuppression in solid organ transplantation. Med Hypotheses 2013;81:731-3. [PMID: 23942029 DOI: 10.1016/j.mehy.2013.07.039] [Reference Citation Analysis]
384 O’Shea DT, Humar A. Life-threatening infection in transplant recipients. Crit Care Clin. 2013;29:953-973. [PMID: 24094386 DOI: 10.1016/j.ccc.2013.06.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
385 Cortazar F, Diaz-Wong R, Roth D, Isakova T. Corticosteroid and calcineurin inhibitor sparing regimens in kidney transplantation. Nephrol Dial Transplant 2013;28:2708-16. [PMID: 23825102 DOI: 10.1093/ndt/gft231] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
386 Liu Y, Yang T, Li H, Li MH, Liu J, Wang YT, Yang SX, Zheng J, Luo XY, Lai Y, Yang P, Li LM, Zou Q. BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3/STAT5 signalling pathway. Br J Pharmacol 2013;168:632-43. [PMID: 22906008 DOI: 10.1111/j.1476-5381.2012.02172.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
387 Lachmann N, Todorova K, Schulze H, Schönemann C. Luminex(®) and its applications for solid organ transplantation, hematopoietic stem cell transplantation, and transfusion. Transfus Med Hemother 2013;40:182-9. [PMID: 23922543 DOI: 10.1159/000351459] [Cited by in Crossref: 54] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
388 English K, Wood KJ. Mesenchymal stromal cells in transplantation rejection and tolerance. Cold Spring Harb Perspect Med 2013;3:a015560. [PMID: 23637312 DOI: 10.1101/cshperspect.a015560] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 6.5] [Reference Citation Analysis]
389 Liu Q, Wang Y, Nakao A, Zhang W, Gorantla V, Zheng XX. Heart allograft tolerance induced and maintained by vascularized hind-limb transplant in rats. Clin Dev Immunol 2013;2013:483856. [PMID: 23573112 DOI: 10.1155/2013/483856] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
390 Afzali B, Edozie FC, Fazekasova H, Scottà C, Mitchell PJ, Canavan JB, Kordasti SY, Chana PS, Ellis R, Lord GM, John S, Hilton R, Lechler RI, Lombardi G. Comparison of regulatory T cells in hemodialysis patients and healthy controls: implications for cell therapy in transplantation. Clin J Am Soc Nephrol 2013;8:1396-405. [PMID: 23580782 DOI: 10.2215/CJN.12931212] [Cited by in Crossref: 57] [Cited by in F6Publishing: 60] [Article Influence: 5.7] [Reference Citation Analysis]
391 Kim HY, Cho ML, Jhun JY, Byun JK, Kim EK, Yim YB, Chung BH, Yoon SK, Bae SH, Kim DG, Yang CW, Choi JY. The imbalance of T helper 17/regulatory T cells and memory B cells during the early post-transplantation period in peripheral blood of living donor liver transplantation recipients under calcineurin inhibitor-based immunosuppression. Immunology 2013;138:124-33. [PMID: 23205589 DOI: 10.1111/imm.12021] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
392 Bernhardt A, Reichenspurner H. Zur ISHLT-Leitlinie: Immunsuppression nach Herztransplantation‬‬‬‬‬. Z Herz- Thorax- Gefäßchir 2013;27:65-72. [DOI: 10.1007/s00398-012-0981-z] [Reference Citation Analysis]
393 Xu X, Ye L, Araki K, Ahmed R. mTOR, linking metabolism and immunity. Semin Immunol 2012;24:429-35. [PMID: 23352227 DOI: 10.1016/j.smim.2012.12.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 6.4] [Reference Citation Analysis]
394 Hecking M, Werzowa J, Haidinger M, Hörl WH, Pascual J, Budde K, Luan FL, Ojo A, de Vries AP, Porrini E. Novel views on new-onset diabetes after transplantation: development, prevention and treatment. Nephrol Dial Transplant. 2013;28:550-566. [PMID: 23328712 DOI: 10.1093/ndt/gfs583] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 8.5] [Reference Citation Analysis]
395 Teuteberg J, Mathier MA, Shullo MA. Cardiac Transplantation and Circulatory Support Devices. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease 2013. [DOI: 10.1016/b978-1-4557-0101-8.00015-1] [Reference Citation Analysis]
396 Isakova T, Xie H, Messinger S, Cortazar F, Scialla JJ, Guerra G, Contreras G, Roth D, Burke GW 3rd, Molnar MZ, Mucsi I, Wolf M. Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation. Am J Transplant 2013;13:100-10. [PMID: 23025566 DOI: 10.1111/j.1600-6143.2012.04281.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 3.7] [Reference Citation Analysis]
397 Sanoff SL. Infectious Disease in Kidney Transplantation. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation 2013. [DOI: 10.1007/978-1-4614-4454-1_37] [Reference Citation Analysis]
398 Cuellar-rodriguez J, Freeman AF. Infections in the immunocompromised host. Clinical Immunology 2013. [DOI: 10.1016/b978-0-7234-3691-1.00049-0] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
399 Kennedy CM, Magee CC. Immunosuppression in the Renal Transplant Recipient. Clinical Decisions in Nephrology, Hypertension and Kidney Transplantation 2013. [DOI: 10.1007/978-1-4614-4454-1_35] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
400 Cravedi P, Ruggenenti P, Remuzzi G. Successes and Disappointments with Clinical Islet Transplantation. Islets of Langerhans, 2. ed. 2013. [DOI: 10.1007/978-94-007-6884-0_23-1] [Reference Citation Analysis]
401 Pilch NA, Meadows HB, Alloway RR. Monoclonal Antibodies in Solid Organ Transplantation. Pharmaceutical Biotechnology 2013. [DOI: 10.1007/978-1-4614-6486-0_19] [Reference Citation Analysis]
402 Costa C, Cavallo R. Polyomavirus-associated nephropathy. World J Transplant 2012; 2(6): 84-94 [PMID: 24175200 DOI: 10.5500/wjt.v2.i6.84] [Cited by in CrossRef: 38] [Cited by in F6Publishing: 40] [Article Influence: 3.5] [Reference Citation Analysis]
403 Gabardi S, Chandraker A. Immunosuppressive Pharmacotherapy. Abdominal Organ Transplantation 2012. [DOI: 10.1002/9781118483664.ch10] [Reference Citation Analysis]
404 Tancré A, Capron A, Wallemacq P. Méthode de dosage de l’Everolimus et du Sirolimus par CL-SM/SM. Immuno-analyse & Biologie Spécialisée 2012;27:345-351. [DOI: 10.1016/j.immbio.2012.07.026] [Reference Citation Analysis]
405 Heiligenhaus A, Zurek-Imhoff B, Roesel M, Hennig M, Rammrath D, Heinz C. Everolimus for the treatment of uveitis refractory to cyclosporine A: a pilot study. Graefes Arch Clin Exp Ophthalmol 2013;251:143-52. [PMID: 23073842 DOI: 10.1007/s00417-012-2163-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
406 Klawitter J, Klawitter J, Schmitz V, Brunner N, Crunk A, Corby K, Bendrick-Peart J, Leibfritz D, Edelstein CL, Thurman JM, Christians U. Low-salt diet and cyclosporine nephrotoxicity: changes in kidney cell metabolism. J Proteome Res 2012;11:5135-44. [PMID: 23057591 DOI: 10.1021/pr300260e] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
407 Soft Drugs. Retrometabolic Drug Design and Targeting 2012. [DOI: 10.1002/9781118407738.ch5] [Reference Citation Analysis]
408 Ippoliti G, D'Armini AM, Lucioni M, Marjieh M, Viganò M. Introduction to the use of belatacept: a fusion protein for the prevention of posttransplant kidney rejection. Biologics 2012;6:355-62. [PMID: 23055693 DOI: 10.2147/BTT.S27565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
409 Huurman VA, van der Torren CR, Gillard P, Hilbrands R, van der Meer-Prins EP, Duinkerken G, Gorus FK, Claas FH, Keymeulen B, Roelen DL, Pipeleers DG, Roep BO. Immune responses against islet allografts during tapering of immunosuppression--a pilot study in 5 subjects. Clin Exp Immunol 2012;169:190-8. [PMID: 22774994 DOI: 10.1111/j.1365-2249.2012.04605.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
410 Patel CG, Ogasawara K, Akhlaghi F. Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus. Xenobiotica 2013;43:229-35. [PMID: 22934787 DOI: 10.3109/00498254.2012.713531] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
411 Riquelme P, Tomiuk S, Kammler A, Fändrich F, Schlitt HJ, Geissler EK, Hutchinson JA. IFN-γ-induced iNOS expression in mouse regulatory macrophages prolongs allograft survival in fully immunocompetent recipients. Mol Ther 2013;21:409-22. [PMID: 22929659 DOI: 10.1038/mt.2012.168] [Cited by in Crossref: 102] [Cited by in F6Publishing: 109] [Article Influence: 9.3] [Reference Citation Analysis]
412 Teng J, Hoo XN, Tan S, Dwyer K. Serum sickness following rabbit anti-thymocyte globulin for acute vascular renal allograft rejection. Clinical Kidney Journal 2012;5:334-335. [DOI: 10.1093/ckj/sfs061] [Reference Citation Analysis]
413 Chung BH, Kim KW, Kim BM, Piao SG, Lim SW, Choi BS, Park CW, Kim YS, Cho ML, Yang CW. Dysregulation of Th17 cells during the early post-transplant period in patients under calcineurin inhibitor based immunosuppression. PLoS One 2012;7:e42011. [PMID: 22848688 DOI: 10.1371/journal.pone.0042011] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
414 Tiwari R, Tsapepas DS, Powell JT, Martin ST. Enhancements in healthcare information technology systems: customizing vendor-supplied clinical decision support for a high-risk patient population. J Am Med Inform Assoc 2013;20:377-80. [PMID: 22813760 DOI: 10.1136/amiajnl-2012-001080] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
415 Kusne S, Vilchez RA, Zanwar P, Quiroz J, Mazur MJ, Heilman RL, Mulligan D, Butel JS. Polyomavirus JC urinary shedding in kidney and liver transplant recipients associated with reduced creatinine clearance. J Infect Dis. 2012;206:875-880. [PMID: 22802433 DOI: 10.1093/infdis/jis469] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
416 Ferrer IR, Wagener ME, Song M, Ford ML. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells. PLoS One 2012;7:e40559. [PMID: 22792369 DOI: 10.1371/journal.pone.0040559] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
417 Macphee IAM, van Gelder T. Immunosuppression. Handbook of Renal and Pancreatic Transplantation 2012. [DOI: 10.1002/9781118305294.ch16] [Reference Citation Analysis]
418 Bajwa SJS, Kulshrestha A. Anaesthesia considerations and challenges during renal transplantation: Current perspectives. Apollo Medicine 2012;9:126-132. [DOI: 10.1016/j.apme.2012.04.003] [Reference Citation Analysis]
419 Fredriksson K, Fielhaber JA, Lam JK, Yao X, Meyer KS, Keeran KJ, Zywicke GJ, Qu X, Yu ZX, Moss J, Kristof AS, Levine SJ. Paradoxical effects of rapamycin on experimental house dust mite-induced asthma. PLoS One 2012;7:e33984. [PMID: 22685525 DOI: 10.1371/journal.pone.0033984] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
420 Jin L, Roehrl MH, Xiao L, He X, Li H, Ge L, Shi B. Crystallization and preliminary crystallographic study of a trypsin-resistant catalytic domain of human calcineurin. Acta Crystallogr Sect F Struct Biol Cryst Commun 2012;68:574-9. [PMID: 22691791 DOI: 10.1107/S1744309112007890] [Reference Citation Analysis]
421 Lóez-Hoyos M, Segundo DS, Arias M. Cellular immunotolerance in the transplant. Adv Exp Med Biol 2012;741:44-59. [PMID: 22457102 DOI: 10.1007/978-1-4614-2098-9_4] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
422 Haubert D, Li J, Saveliev A, Calzascia T, Sutter E, Metzler B, Kaiser D, Tybulewicz VL, Weckbecker G. Vav1 GEF activity is required for T cell mediated allograft rejection. Transpl Immunol 2012;26:212-9. [PMID: 22456277 DOI: 10.1016/j.trim.2012.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
423 Chen HD, Zhou X, Yu G, Zhao YL, Ren Y, Zhou YD, Li Q, Zhang XL. Knockdown of core 1 beta 1, 3-galactosyltransferase prolongs skin allograft survival with induction of galectin-1 secretion and suppression of CD8+ T cells: T synthase knockdown effects on galectin-1 and CD8+ T cells. J Clin Immunol 2012;32:820-36. [PMID: 22392045 DOI: 10.1007/s10875-012-9653-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
424 Burrell BE, Bromberg JS. Fates of CD4+ T cells in a tolerant environment depend on timing and place of antigen exposure. Am J Transplant 2012;12:576-89. [PMID: 22176785 DOI: 10.1111/j.1600-6143.2011.03879.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
425 Fernandez A, Landaburu F, Lopez-Daneri G, Nagel C, Di Giorgio P, Iovannitti C, Tokumoto M, Mujica MT. Phenotypic and molecular identification of Coccidioides posadasii in a patient evaluated for bilateral lung transplantation. Rev Iberoam Micol 2012;29:245-8. [PMID: 22366717 DOI: 10.1016/j.riam.2012.01.007] [Reference Citation Analysis]
426 Krummey SM, Ford ML. Heterogeneity within T Cell Memory: Implications for Transplant Tolerance. Front Immunol. 2012;3:36. [PMID: 22566919 DOI: 10.3389/fimmu.2012.00036] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
427 Li Q, Rao R, Vazzana J, Goedegebuure P, Odunsi K, Gillanders W, Shrikant PA. Regulating mammalian target of rapamycin to tune vaccination-induced CD8(+) T cell responses for tumor immunity. J Immunol 2012;188:3080-7. [PMID: 22379028 DOI: 10.4049/jimmunol.1103365] [Cited by in Crossref: 64] [Cited by in F6Publishing: 69] [Article Influence: 5.8] [Reference Citation Analysis]
428 Ware N. The role of genetics in drug dosing. Pediatr Nephrol 2012;27:1489-98. [PMID: 22358188 DOI: 10.1007/s00467-012-2105-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
429 Ritter T, Griffin MD. Gene Therapy in Organ Transplantation. Molecular and Cellular Therapeutics 2012. [DOI: 10.1002/9781119967309.ch9] [Reference Citation Analysis]
430 Mencarelli F, Marks SD. Non-viral infections in children after renal transplantation. Pediatr Nephrol 2012;27:1465-76. [PMID: 22318475 DOI: 10.1007/s00467-011-2099-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
431 Cortazar F, Molnar MZ, Isakova T, Czira ME, Kovesdy CP, Roth D, Mucsi I, Wolf M. Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin. Am J Transplant 2012;12:379-87. [PMID: 22054244 DOI: 10.1111/j.1600-6143.2011.03826.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
432 Dupuis R, Yuen A, Innocenti F. The influence of UGT polymorphisms as biomarkers in solid organ transplantation. Clin Chim Acta. 2012;413:1318-1325. [PMID: 22327003 DOI: 10.1016/j.cca.2012.01.031] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
433 Adams AB, Kirk AD, Larsen CP. Transplantation Immunobiology and Immunosuppression. Sabiston Textbook of Surgery 2012. [DOI: 10.1016/b978-1-4377-1560-6.00026-3] [Reference Citation Analysis]
434 Cannon GW. Immunosuppressing Drugs Including Corticosteroids. Goldman's Cecil Medicine 2012. [DOI: 10.1016/b978-1-4377-1604-7.00034-8] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
435 Gabardi S, Tichy EM. Overview of Immunosuppressive Therapies in Renal Transplantation. Core Concepts in Renal Transplantation 2012. [DOI: 10.1007/978-1-4614-0008-0_6] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
436 Tolkoff-rubin N. Treatment of Irreversible Renal Failure. Goldman's Cecil Medicine 2012. [DOI: 10.1016/b978-1-4377-1604-7.00133-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
437 Tan JC, Busque S, Scandling JD. Clinical Management. Brenner and Rector's The Kidney 2012. [DOI: 10.1016/b978-1-4160-6193-9.10072-7] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
438 Offermanns S. Immunsuppressiva. Pharmakologie & Toxikologie 2012. [DOI: 10.1007/978-3-642-12354-2_25] [Reference Citation Analysis]
439 Tso GH, He J, Chan CW. Engineering of the immune system for human ESC- and iPSC-derived grafts. Drug Discovery Today: Disease Models 2012;9:e171-e178. [DOI: 10.1016/j.ddmod.2012.09.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
440 Rutebemberwa A, Rosen HR. Of mice and men, calcineurin inhibitors and hepatitis C. Liver Transpl 2012;18:1-4. [PMID: 22034173 DOI: 10.1002/lt.22458] [Reference Citation Analysis]
441 Barry JM, Conlin MJ. Renal Transplantation. Campbell-Walsh Urology 2012. [DOI: 10.1016/b978-1-4160-6911-9.00043-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
442 Wiesner RH. Immunosuppression: The Global Picture. Schiff's Diseases of the Liver 2011. [DOI: 10.1002/9781119950509.ch43] [Reference Citation Analysis]
443 Kawahara T, Asthana S, Kneteman NM. m-TOR inhibitors: what role in liver transplantation? J Hepatol 2011;55:1441-51. [PMID: 21781947 DOI: 10.1016/j.jhep.2011.06.015] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.0] [Reference Citation Analysis]
444 Wiesner RH, Fung JJ. Present state of immunosuppressive therapy in liver transplant recipients. Liver Transpl 2011;17 Suppl 3:S1-9. [PMID: 21850697 DOI: 10.1002/lt.22410] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 6.7] [Reference Citation Analysis]
445 Cowan ML, Sciammas R, Chong AS. Experimental models of B cell tolerance in transplantation. Semin Immunol 2012;24:77-85. [PMID: 21925896 DOI: 10.1016/j.smim.2011.08.018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
446 Rostaing L, Neumayer HH, Reyes-Acevedo R, Bresnahan B, Florman S, Vitko S, Heifets M, Xing J, Thomas D, Vincenti F. Belatacept-versus cyclosporine-based immunosuppression in renal transplant recipients with pre-existing diabetes. Clin J Am Soc Nephrol. 2011;6:2696-2704. [PMID: 21921152 DOI: 10.2215/cjn.00270111] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
447 Chakera A, Bennett SC, Cornall RJ. A whole blood monokine-based reporter assay provides a sensitive and robust measurement of the antigen-specific T cell response. J Transl Med 2011;9:143. [PMID: 21871084 DOI: 10.1186/1479-5876-9-143] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
448 von Vietinghoff S, Koltsova EK, Mestas J, Diehl CJ, Witztum JL, Ley K. Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation. J Am Coll Cardiol 2011;57:2194-204. [PMID: 21596236 DOI: 10.1016/j.jacc.2010.12.030] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.4] [Reference Citation Analysis]
449 Afzali B, Mitchell PJ, Scottà C, Canavan J, Edozie FC, Fazekasova H, Lord GM, John S, Barber LD, Hernandez-Fuentes MP, Lechler RI, Lombardi G. Relative resistance of human CD4(+) memory T cells to suppression by CD4(+) CD25(+) regulatory T cells. Am J Transplant 2011;11:1734-42. [PMID: 21749646 DOI: 10.1111/j.1600-6143.2011.03635.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
450 Saeb-parsy K, Watson C. Kidney transplantation: surgical aspects. Medicine 2011;39:443-447. [DOI: 10.1016/j.mpmed.2011.05.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
451 Scolari M, Cornai G, d'Arcangelo GL, Todeschini P, Mosconi G, La Manna G, Feliciangeli G, Stefoni S. Schemi di terapia immunosoppressiva e livelli ematici consigliati. Giornale di Tecniche Nefrologiche e Dialitiche 2011;23:48-52. [DOI: 10.1177/039493621102300311] [Reference Citation Analysis]
452 Kobashigawa J, Crespo-Leiro MG, Ensminger SM, Reichenspurner H, Angelini A, Berry G, Burke M, Czer L, Hiemann N, Kfoury AG, Mancini D, Mohacsi P, Patel J, Pereira N, Platt JL, Reed EF, Reinsmoen N, Rodriguez ER, Rose ML, Russell SD, Starling R, Suciu-Foca N, Tallaj J, Taylor DO, Van Bakel A, West L, Zeevi A, Zuckermann A; Consensus Conference Participants. Report from a consensus conference on antibody-mediated rejection in heart transplantation. J Heart Lung Transplant 2011;30:252-69. [PMID: 21300295 DOI: 10.1016/j.healun.2010.11.003] [Cited by in Crossref: 282] [Cited by in F6Publishing: 225] [Article Influence: 23.5] [Reference Citation Analysis]
453 Imamovic G, Zerem E, Osmanovic E. Survival of living-related kidney graft recipients in the era of modern immunosuppressive treatment. Ann Saudi Med 2011;31:279-83. [PMID: 21623058 DOI: 10.4103/0256-4947.81546] [Reference Citation Analysis]
454 Mehl ML, Tell L, Kyles AE, Chen YJ, Craigmill A, Gregory CR. Pharmacokinetics and pharmacodynamics of A77 1726 and leflunomide in domestic cats. J Vet Pharmacol Ther 2012;35:139-46. [PMID: 21615755 DOI: 10.1111/j.1365-2885.2011.01306.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
455 Pilat N, Sayegh MH, Wekerle T. Costimulatory pathways in transplantation. Semin Immunol. 2011;23:293-303. [PMID: 21616680 DOI: 10.1016/j.smim.2011.04.002] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
456 Miller JB, Venkat KK. The Renal Transplant Patient. Challenging and Emerging Conditions in Emergency Medicine 2011. [DOI: 10.1002/9781119971603.ch4] [Reference Citation Analysis]
457 Imamovic G, Zerem E, Osmanovic E. Survival of Living-Related Kidney Graft Recipients in the Era of Modern Immunosuppressive Treatment. Ann Saudi Med 2011;31:279-283. [DOI: 10.5144/0256-4947.2011.279] [Reference Citation Analysis]
458 Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, Dumortier J, Cannesson A, Cassuto-Viguier E, Thervet E, Conti F, Lebray P, Dalton HR, Santella R, Kanaan N, Essig M, Mousson C, Radenne S, Roque-Afonso AM, Izopet J, Rostaing L. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011;140:1481-9. [PMID: 21354150 DOI: 10.1053/j.gastro.2011.02.050] [Cited by in Crossref: 468] [Cited by in F6Publishing: 482] [Article Influence: 39.0] [Reference Citation Analysis]
459 Snanoudj R, Zuber J, Legendre C. Co-stimulation blockade as a new strategy in kidney transplantation: benefits and limits. Drugs 2010;70:2121-31. [PMID: 20964456 DOI: 10.2165/11538140-000000000-00000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
460 Balssa L, Bittard H, Kleinclauss F; Comité de transplantation de l'Association française d'urologie. [Immunosuppression in kidney transplantation]. Prog Urol 2011;21:250-3. [PMID: 21482398 DOI: 10.1016/j.purol.2010.08.048] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
461 Li XC. The significance of non-T-cell pathways in graft rejection: implications for transplant tolerance. Transplantation. 2010;90:1043-1047. [PMID: 20686444 DOI: 10.1097/tp.0b013e3181efcfe9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
462 de Rham C, Villard J. How to cross immunogenetic hurdles to human embryonic stem cell transplantation. Semin Immunopathol 2011;33:525-34. [PMID: 21461719 DOI: 10.1007/s00281-011-0262-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
463 Ferrer IR, Araki K, Ford ML. Paradoxical aspects of rapamycin immunobiology in transplantation. Am J Transplant 2011;11:654-9. [PMID: 21446969 DOI: 10.1111/j.1600-6143.2011.03473.x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
464 Manikwar P, Kiptoo P, Badawi AH, Büyüktimkin B, Siahaan TJ. Antigen-specific blocking of CD4-specific immunological synapse formation using BPI and current therapies for autoimmune diseases. Med Res Rev 2012;32:727-64. [PMID: 21433035 DOI: 10.1002/med.20243] [Cited by in Crossref: 17] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
465 Sun Q, Zimmerer JM, Hadley GA. Immunology of transplantation. Primer on Transplantation 2011. [DOI: 10.1002/9781444391770.ch1] [Reference Citation Analysis]
466 Turner AP, Shaffer VO, Araki K, Martens C, Turner PL, Gangappa S, Ford ML, Ahmed R, Kirk AD, Larsen CP. Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques. Am J Transplant 2011;11:613-8. [PMID: 21342450 DOI: 10.1111/j.1600-6143.2010.03407.x] [Cited by in Crossref: 85] [Cited by in F6Publishing: 86] [Article Influence: 7.1] [Reference Citation Analysis]
467 Charpentier B, Beaudreuil S, Francois H, Jacquet A, Durrbach A. Histoire du progrès médical en transplantation rénale. À propos d’une série de 3 000 transplantations consécutives réalisées dans le CHU de Bicêtre. Bulletin de l'Académie Nationale de Médecine 2011;195:335-350. [DOI: 10.1016/s0001-4079(19)32092-8] [Reference Citation Analysis]
468 Thomas G, Nurko S, Srinivas TR. Immunosuppressive Therapy in Kidney and Pancreas Transplantation. Kidney and Pancreas Transplantation 2011. [DOI: 10.1007/978-1-60761-642-9_3] [Reference Citation Analysis]
469 SUGGESTED READINGS. Basic Immunology 2011. [DOI: 10.1016/b978-1-4160-5569-3.50016-0] [Reference Citation Analysis]
470 Naito T. Evidence-based Pharmaceutical Care with Immunosuppressants Using Therapeutic Drug Monitoring in Clinical Practice. Jpn J Pharm Health Care Sci 2011;37:277-287. [DOI: 10.5649/jjphcs.37.277] [Reference Citation Analysis]
471 Sánchez-Fueyo A, Strom TB. Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 2011;140:51-64. [PMID: 21073873 DOI: 10.1053/j.gastro.2010.10.059] [Cited by in Crossref: 166] [Cited by in F6Publishing: 171] [Article Influence: 13.8] [Reference Citation Analysis]
472 Piot-ziegler C, Pascual M. Prise en charge psychologique en transplantation d'organes : quel accompagnement pour les patients ? EMC - Psychiatrie 2011;8:1-11. [DOI: 10.1016/s0246-1072(11)52763-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
473 Chen QP, Aw DC. Epidemiology of Skin Diseases in Renal Transplant Recipients in a Tertiary Hospital. Ann Acad Med Singap 2010;39:904-908. [DOI: 10.47102/annals-acadmedsg.v39n12p904] [Reference Citation Analysis]
474 Selzner N, Grant DR, Shalev I, Levy GA. The immunosuppressive pipeline: meeting unmet needs in liver transplantation. Liver Transpl 2010;16:1359-72. [PMID: 21117245 DOI: 10.1002/lt.22193] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
475 Imamović G, Zerem E, Osmanović E. Kidney graft outcomes in living-related transplantation have improved with substitution of basiliximab and mycophenolate mofetil for antithymocyte globulin and azathioprine: a single center retrospective cohort study. Eur J Intern Med 2010;21:524-9. [PMID: 21111938 DOI: 10.1016/j.ejim.2010.09.012] [Reference Citation Analysis]
476 Li XC, Raghavan M. Structure and function of major histocompatibility complex class I antigens. Curr Opin Organ Transplant 2010;15:499-504. [PMID: 20613521 DOI: 10.1097/MOT.0b013e32833bfb33] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
477 Bernasconi R, Soldà T, Galli C, Pertel T, Luban J, Molinari M. Cyclosporine A-sensitive, cyclophilin B-dependent endoplasmic reticulum-associated degradation. PLoS One 2010;5:e13008. [PMID: 20927389 DOI: 10.1371/journal.pone.0013008] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
478 Dell'Oglio MP, Zaza G, Rossini M, Divella C, Pontrelli P, Verrienti R, Rutigliano M, Ditonno P, Stifanelli P, Ancona N, Schena FP, Grandaliano G. The anti-fibrotic effect of mycophenolic acid-induced neutral endopeptidase. J Am Soc Nephrol 2010;21:2157-68. [PMID: 20864690 DOI: 10.1681/ASN.2010020181] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
479 Guo ZS, Parimi V, O'Malley ME, Thirunavukarasu P, Sathaiah M, Austin F, Bartlett DL. The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. Gene Ther 2010;17:1465-75. [PMID: 20703311 DOI: 10.1038/gt.2010.104] [Cited by in Crossref: 35] [Cited by in F6Publishing: 39] [Article Influence: 2.7] [Reference Citation Analysis]
480 Kukreja N, Onuma Y, Serruys PW. Coronary Stent Technology. Cardiovascular Interventions in Clinical Practice 2010. [DOI: 10.1002/9781444316704.ch34] [Reference Citation Analysis]
481 Mas VR, Archer KJ, Scian M, Maluf DG. Molecular pathways involved in loss of graft function in kidney transplant recipients. Expert Rev Mol Diagn 2010;10:269-84. [PMID: 20370585 DOI: 10.1586/erm.10.6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
482 Freue GV, Sasaki M, Meredith A, Günther OP, Bergman A, Takhar M, Mui A, Balshaw RF, Ng RT, Opushneva N, Hollander Z, Li G, Borchers CH, Wilson-McManus J, McManus BM, Keown PA, McMaster WR; Genome Canada Biomarkers in Transplantation Group. Proteomic signatures in plasma during early acute renal allograft rejection. Mol Cell Proteomics 2010;9:1954-67. [PMID: 20501940 DOI: 10.1074/mcp.M110.000554] [Cited by in Crossref: 71] [Cited by in F6Publishing: 74] [Article Influence: 5.5] [Reference Citation Analysis]
483 Sklavos MM, Bertera S, Tse HM, Bottino R, He J, Beilke JN, Coulombe MG, Gill RG, Crapo JD, Trucco M, Piganelli JD. Redox modulation protects islets from transplant-related injury. Diabetes 2010;59:1731-8. [PMID: 20413509 DOI: 10.2337/db09-0588] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 4.2] [Reference Citation Analysis]
484 Kuypers DR, Ekberg H, Grinyó J, Nashan B, Vincenti F, Snell P, Mamelok RD, Bouw RM. Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients. Clin Pharmacokinet 2009;48:329-41. [PMID: 19566116 DOI: 10.2165/00003088-200948050-00005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.8] [Reference Citation Analysis]
485 Strijack B, Keown PA. Cyclosporine: Molecular Action to Clinical Therapeutics. Immunotherapy in Transplantation 2010. [DOI: 10.1002/9781444355628.ch15] [Reference Citation Analysis]
486 Mandelbrot DA, Burrell B, Sayegh MH, Heeger PS. The T Cell Response to Transplantation Antigens. Immunotherapy in Transplantation 2010. [DOI: 10.1002/9781444355628.ch3] [Reference Citation Analysis]
487 Bodor N, Buchwald P. Retrometabolism‐Based Drug Design and Targeting. Burger's Medicinal Chemistry and Drug Discovery 2010. [DOI: 10.1002/0471266949.bmc035.pub2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
488 Azim S, Chun L. Kidney transplant. Core Clinical Competencies in Anesthesiology 2010. [DOI: 10.1017/cbo9780511730092.036] [Reference Citation Analysis]
489 van Walraven C, Austin PC, Knoll G. Predicting potential survival benefit of renal transplantation in patients with chronic kidney disease. CMAJ 2010;182:666-72. [PMID: 20351122 DOI: 10.1503/cmaj.091661] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
490 Alarrayed SM, El-Agroudy AE, Alarrayed AS, Al Ghareeb SM, Garadah TS, El-Sharqawi SY, Al-Aradi AH, Dandi BG, Abdulla S. Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience. Clin Exp Nephrol. 2010;14:248-255. [PMID: 20232105 DOI: 10.1007/s10157-010-0269-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
491 Morath C, Zeier M, Sommerer C. Immunsuppression nach Nierentransplantation. Nephrologe 2010;5:108-117. [DOI: 10.1007/s11560-009-0370-0] [Reference Citation Analysis]
492 Octavio Rojas G, Vania Krauskopf P, Juan Agustín Umaña M, Rodrigo Erazo R. Intervención psiquiátrica en programa de trasplantes. Revista Médica Clínica Las Condes 2010;21:286-92. [DOI: 10.1016/s0716-8640(10)70536-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
493 Budde K, Schütz M. Immunsuppression: neue Entwicklungen. Nephrologe 2010;5:133-141. [DOI: 10.1007/s11560-009-0373-x] [Reference Citation Analysis]
494 Gustafson MP, Lin Y, New KC, Bulur PA, O'Neill BP, Gastineau DA, Dietz AB. Systemic immune suppression in glioblastoma: the interplay between CD14+HLA-DRlo/neg monocytes, tumor factors, and dexamethasone. Neuro Oncol 2010;12:631-44. [PMID: 20179016 DOI: 10.1093/neuonc/noq001] [Cited by in Crossref: 151] [Cited by in F6Publishing: 163] [Article Influence: 11.6] [Reference Citation Analysis]
495 Ayala-García MA, Soel JM, Diaz E, González B, Paz FJ, Cervantes F, Rodea E, Muñoz G, Rodriguez JS, Gutiérrez J, Malacara JM. Induction of tolerance in renal transplantation using splenic transplantation: experimental study in a canine model. Transplant Proc 2010;42:376-80. [PMID: 20172353 DOI: 10.1016/j.transproceed.2009.11.009] [Reference Citation Analysis]
496 Goebel J, Defoor W, Sheldon C. PEDIATRIC RENAL TRANSPLANTATION. Pediatric Urology 2010. [DOI: 10.1016/b978-1-4160-3204-5.00047-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
497 Seger C, Vogeser M. Immunosuppressant drug monitoring – a routine undertaking? 1. LaboratoriumsMedizin 2010;34:-. [DOI: 10.1515/jlm.2010.027et] [Reference Citation Analysis]
498 Gaston RS. Evaluation of Renal Allograft Dysfunction. Kidney Transplantation: A Guide to the Care of Kidney Transplant Recipients 2010. [DOI: 10.1007/978-1-4419-1690-7_11] [Reference Citation Analysis]
499 Vo AA, Chaux GE, Falk JA. Transplant Pharmacology. Medical Management of the Thoracic Surgery Patient 2010. [DOI: 10.1016/b978-1-4160-3993-8.00040-4] [Reference Citation Analysis]
500 Reese PP, Blumberg EA, Bloom RD. Kidney transplantation in patients with HIV infection. Adv Chronic Kidney Dis 2010;17:94-101. [PMID: 20005493 DOI: 10.1053/j.ackd.2009.08.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
501 Cavanaugh K, Ikizler TA. Chronic Renal Failure. Andreoli and Carpenter's Cecil Essentials of Medicine 2010. [DOI: 10.1016/b978-1-4160-6109-0.00033-2] [Reference Citation Analysis]
502 Arruda VR. Modulating Immune Responses in Muscle Gene Therapy. Muscle Gene Therapy 2010. [DOI: 10.1007/978-1-4419-1207-7_11] [Reference Citation Analysis]
503 Issa N, Braun WE. Immunosuppression for Renal Transplant Patients and Common Medical Problems in Renal Transplantation. Current Clinical Medicine 2010. [DOI: 10.1016/b978-1-4160-6643-9.00133-8] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
504 Lammi MR, Thacker J, Patel N. ICU Care of the Solid Organ Transplant Recipient. Critical Care Study Guide 2010. [DOI: 10.1007/978-0-387-77452-7_41] [Reference Citation Analysis]
505 Jordan SC, Toyoda M. Transplant Immunology. Medical Management of the Thoracic Surgery Patient 2010. [DOI: 10.1016/b978-1-4160-3993-8.00041-6] [Reference Citation Analysis]
506 Dummer JS, Thomas LD. Risk Factors and Approaches to Infections in Transplant Recipients. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2010. [DOI: 10.1016/b978-0-443-06839-3.00310-6] [Reference Citation Analysis]
507 Abbas AK, Lichtman AH, Pillai S, Baker DL. TRANSPLANTATION IMMUNOLOGY. Cellular and Molecular Immunology 2010. [DOI: 10.1016/b978-1-4160-3123-9.50025-5] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
508 Cravedi P, van der Meer IM, Cattaneo S, Ruggenenti P, Remuzzi G. Successes and disappointments with clinical islet transplantation. Adv Exp Med Biol 2010;654:749-69. [PMID: 20217523 DOI: 10.1007/978-90-481-3271-3_33] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
509 Seger C, Vogeser M. Immunsuppressiva-Medikamentenspiegelmessung – reine Routine? / Immunosuppressant drug monitoring: a routine undertaking? LaboratoriumsMedizin 2010;34:117-128. [DOI: 10.1515/jlm.2010.027] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
510 Jordan JA, Manley K, Dugan AS, O’Hara BA, Atwood WJ. Transcriptional regulation of BK virus by nuclear factor of activated T cells. J Virol. 2010;84:1722-1730. [PMID: 19955309 DOI: 10.1128/jvi.01918-09] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
511 Zaza G, Granata S, Sallustio F, Grandaliano G, Schena FP. Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients. Clin Exp Immunol 2010;159:268-80. [PMID: 19968662 DOI: 10.1111/j.1365-2249.2009.04065.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
512 Mundel P, Reiser J. Proteinuria: an enzymatic disease of the podocyte? Kidney Int 2010;77:571-80. [PMID: 19924101 DOI: 10.1038/ki.2009.424] [Cited by in Crossref: 203] [Cited by in F6Publishing: 211] [Article Influence: 14.5] [Reference Citation Analysis]
513 Alkharfy KM. Influence of overt diabetes mellitus on cyclosporine pharmacokinetics in a canine model. Exp Diabetes Res 2009;2009:363787. [PMID: 19859566 DOI: 10.1155/2009/363787] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
514 Tan JY, Wu YM, Yang KH, Ma B, Pang HL, Tian JH, Jiang L, Bai ZG, Li Y. FTY720 immunosuppression for kidney transplant recipients. Cochrane Database of Systematic Reviews 2009. [DOI: 10.1002/14651858.cd008010] [Reference Citation Analysis]
515 Wagner M, Balk EM, Kent DM, Kasiske BL, Ekberg H. Subgroup analyses in randomized controlled trials: the need for risk stratification in kidney transplantation. Am J Transplant 2009;9:2217-22. [PMID: 19764948 DOI: 10.1111/j.1600-6143.2009.02802.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
516 Naesens M, Lerut E, de Jonge H, Van Damme B, Vanrenterghem Y, Kuypers DR. Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts. J Am Soc Nephrol. 2009;20:2468-2480. [PMID: 19762492 DOI: 10.1681/asn.2009020192] [Cited by in Crossref: 108] [Cited by in F6Publishing: 116] [Article Influence: 7.7] [Reference Citation Analysis]
517 Arruda VR, Favaro P, Finn JD. Strategies to modulate immune responses: a new frontier for gene therapy. Mol Ther 2009;17:1492-503. [PMID: 19584819 DOI: 10.1038/mt.2009.150] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.1] [Reference Citation Analysis]
518 Yabu JM, Vincenti F. Kidney transplantation: the ideal immunosuppression regimen. Adv Chronic Kidney Dis 2009;16:226-33. [PMID: 19576552 DOI: 10.1053/j.ackd.2009.04.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
519 Ljuca F, Imamović S, Mesić D, Hasukić SH, Omerović S, Bazardzanović M, Iljazagić-Halilović F. Micophenolat Mofetil versus Azathioprine: effects on renal graft function in early posttransplant period. Bosn J Basic Med Sci 2009;9:156-60. [PMID: 19485949 DOI: 10.17305/bjbms.2009.2836] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
520 Cattaneo D, Ruggenenti P, Baldelli S, Motterlini N, Gotti E, Sandrini S, Salvadori M, Segoloni G, Rigotti P, Donati D, Perico N, Remuzzi G; Mycophenolate Steroids Sparing (MYSS) Genetics Study Group. ABCB1 genotypes predict cyclosporine-related adverse events and kidney allograft outcome. J Am Soc Nephrol 2009;20:1404-15. [PMID: 19470683 DOI: 10.1681/ASN.2008080819] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 4.1] [Reference Citation Analysis]
521 Golshayan D, Pascual M, Vogt B. Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability. Ther Clin Risk Manag 2009;5:341-51. [PMID: 19753127 DOI: 10.2147/tcrm.s3496] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
522 Braun W. Transplantation: sirolimus plus calcineurin inhibitors in transplantation. Nat Rev Nephrol 2009;5:252-4. [PMID: 19384324 DOI: 10.1038/nrneph.2009.55] [Reference Citation Analysis]
523 Machnicki G, Ricci JF, Brennan DC, Schnitzler MA. Economic impact and long-term graft outcomes of mycophenolate mofetil dosage modifications following gastrointestinal complications in renal transplant recipients. Pharmacoeconomics 2008;26:951-67. [PMID: 18850764 DOI: 10.2165/00019053-200826110-00007] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
524 Mannon RB. Post-transplantation Monitoring and Outcomes. Primer on Kidney Diseases 2009. [DOI: 10.1016/b978-1-4160-5185-5.00063-8] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
525 Chaballa M, Filicko-o'hara J, Holt D, Frank AM, Wagner JL, Grosso D, Flomenberg N. TRANSPLANT MEDICINE. Pharmacology and Therapeutics 2009. [DOI: 10.1016/b978-1-4160-3291-5.50096-2] [Reference Citation Analysis]
526 Wen J, Li L, Chen J, Ji S, Zheng C, Liu Z. Tripterygium wilfordii hook f increase the blood concentration of tacrolimus. Transplant Proc 2008;40:3679-82. [PMID: 19100464 DOI: 10.1016/j.transproceed.2008.08.132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
527 Tredger JM, Brown NW, Dhawan A. Calcineurin inhibitor sparing in paediatric solid organ transplantation : managing the efficacy/toxicity conundrum. Drugs 2008;68:1385-414. [PMID: 18578558 DOI: 10.2165/00003495-200868100-00004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
528 Goebel J. Renal Issues in Organ Transplant Recipients in the PICU. Pediatric Nephrology in the ICU. [DOI: 10.1007/978-3-540-74425-2_18] [Reference Citation Analysis]
529 Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, Chang JM, Choi HY, Campbell KN, Kim K, Reiser J, Mundel P. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931-8. [PMID: 18724379 DOI: 10.1038/nm.1857] [Cited by in Crossref: 704] [Cited by in F6Publishing: 733] [Article Influence: 46.9] [Reference Citation Analysis]
530 Nakazawa G, Tanabe K, Aoki J, Onuma Y, Higashikuni Y, Yamamoto H, Ohtsuki S, Yachi S, Yagishita A, Nakajima H, Hara K. Sirolimus-eluting stents suppress neointimal formation irrespective of metallic allergy. Circ J 2008;72:893-6. [PMID: 18503212 DOI: 10.1253/circj.72.893] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
531 Rosen HR. Transplantation immunology: what the clinician needs to know for immunotherapy. Gastroenterology 2008;134:1789-801. [PMID: 18471555 DOI: 10.1053/j.gastro.2008.02.062] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 2.9] [Reference Citation Analysis]
532 Rubio-Tapia A, Abdulkarim AS, Wiesner RH, Moore SB, Krause PK, Murray JA. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int 2008;28:467-76. [PMID: 18339073 DOI: 10.1111/j.1478-3231.2008.01681.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
533 Vavić N, Ignjatović L, Drasković B, Hrvacević R, Kovacević Z, Paunić Z. [Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation]. Vojnosanit Pregl 2008;65:119-27. [PMID: 18365668 DOI: 10.2298/vsp0802119v] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
534 Rabets JC, Goldfarb DA. Renal Cell Carcinoma in Patients with End-Stage Renal Disease. Clinical Management of Renal Tumors 2008. [DOI: 10.1007/978-1-60327-149-3_33] [Reference Citation Analysis]
535 Schröppel B, Akalin E. Transplant Immunology and Immunosuppression. Therapy in Nephrology & Hypertension 2008. [DOI: 10.1016/b978-141605484-9.50089-7] [Reference Citation Analysis]
536 Khan MM. Immunosuppressive Agents. Immunopharmacology 2008. [DOI: 10.1007/978-0-387-77976-8_4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
537 Karam G, Maillet F, Braud G, Battisti S, Hétet J, Glémain P, Le Normand L, Bouchot O, Rigaud J. Complications chirurgicales de la transplantation rénale. EMC - Urologie 2008;1:1-12. [DOI: 10.1016/s1762-0953(06)75012-9] [Reference Citation Analysis]
538 Nelson PJ, Segerer S, Schlondorff D. Chemokines in Transplantation Biology. The Receptors. [DOI: 10.1007/978-1-59745-020-1_9] [Reference Citation Analysis]
539 Zhu R, Snyder AH, Kharel Y, Schaffter L, Sun Q, Kennedy PC, Lynch KR, Macdonald TL. Asymmetric synthesis of conformationally constrained fingolimod analogues--discovery of an orally active sphingosine 1-phosphate receptor type-1 agonist and receptor type-3 antagonist. J Med Chem 2007;50:6428-35. [PMID: 17994678 DOI: 10.1021/jm7010172] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.2] [Reference Citation Analysis]
540 Trullas JC, Cofan F, Cocchi S, Cervera C, Linares L, Aguero F, Oppenheimer F, Moreno A, Campistol JM, Miró JM. Effect of thymoglobulin induction on HIV-infected renal transplant recipients: differences between HIV-positive and HIV-negative patients. AIDS Res Hum Retroviruses 2007;23:1161-5. [PMID: 17961099 DOI: 10.1089/aid.2007.0015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
541 Shen LJ, Wu FL. Nanomedicines in renal transplant rejection--focus on sirolimus. Int J Nanomedicine 2007;2:25-32. [PMID: 17722509 DOI: 10.2147/nano.2007.2.1.25] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
542 Morton LM, Landgren O, Chatterjee N, Castenson D, Parsons R, Hoover RN, Engels EA. Hepatitis C virus infection and risk of posttransplantation lymphoproliferative disorder among solid organ transplant recipients. Blood 2007;110:4599-605. [PMID: 17855632 DOI: 10.1182/blood-2007-07-101956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 1.6] [Reference Citation Analysis]
543 Tao R, de Zoeten EF, Ozkaynak E, Wang L, Li B, Greene MI, Wells AD, Hancock WW. Histone deacetylase inhibitors and transplantation. Curr Opin Immunol 2007;19:589-95. [PMID: 17719760 DOI: 10.1016/j.coi.2007.07.015] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
544 DELAYED GRAFT FUNCTION. Medical Complications of Kidney Transplantation 2007. [DOI: 10.3109/9780203089903-5] [Reference Citation Analysis]
545 Callaghan C, Andrew Bradley J. Quiz. The Foundation Years 2007;3:97-98. [DOI: 10.1016/j.mpfou.2007.02.002] [Reference Citation Analysis]
546 Skotnicki J, Huryn D. Treatment of Transplantation Rejection and Multiple Sclerosis. Comprehensive Medicinal Chemistry II 2007. [DOI: 10.1016/b0-08-045044-x/00233-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
547 Yeh H, Bortecen KH, Shaked A, Markmann JF. Renal Transplantation. Penn Clinical Manual of Urology 2007. [DOI: 10.1016/b978-141603848-1.10023-3] [Reference Citation Analysis]
548 Crespo Leiro MG, Almenar Bonet L, Alonso-pulpón L, Campreciós M, Cuenca Castillo JJ, de la Fuente Galván L, Delgado Jiménez J, García Guereta L, Manito Lorite N, Maroto C, Palomo J, Pascual Figal D, Lage Gallé E, Rodríguez Lambert JL, Roig i Minguell E, Sanz Julve ML, Vázquez de Prada JA. Conferencia de Consenso de los Grupos Españoles de Trasplante Cardiaco. Revista Española de Cardiología Suplementos 2007;7:4B-54B. [DOI: 10.1016/s1131-3587(07)75240-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
549 Mcleod BC. Therapeutic Plasma Exchange. Blood Banking and Transfusion Medicine 2007. [DOI: 10.1016/b978-0-443-06981-9.50060-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
550 Pollinger HS, Burns JM, Casingal VP, Gores PF. Current Immunosuppressive Drugs and Clinical Use. Cellular Transplantation 2007. [DOI: 10.1016/b978-012369415-7/50003-x] [Reference Citation Analysis]
551 Tan HP, Smaldone MC, Shapiro R. Immunosuppressive preconditioning or induction regimens : evidence to date. Drugs 2006;66:1535-45. [PMID: 16956302 DOI: 10.2165/00003495-200666120-00001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
552 Stypinski D, Obaidi M, Combs M, Weber M, Stewart AJ, Ishikawa H. Safety, tolerability and pharmacokinetics of higher-dose mizoribine in healthy male volunteers. Br J Clin Pharmacol 2007;63:459-68. [PMID: 17096684 DOI: 10.1111/j.1365-2125.2006.02779.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.3] [Reference Citation Analysis]
553 Lorber MI. High-volume kidney transplantation in a developing economy. Transplantation 2006;81:1521-2. [PMID: 16770239 DOI: 10.1097/01.tp.0000214936.77784.eb] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
554 Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clin Microbiol Rev. 2006;19:338-381. [PMID: 16614253 DOI: 10.1128/cmr.19.2.338-381.2006] [Cited by in Crossref: 521] [Cited by in F6Publishing: 428] [Article Influence: 30.6] [Reference Citation Analysis]
555 Wallace CJ, Kingsmore DB. Transplantation and immunosuppressive therapy. Anaesthesia & Intensive Care Medicine 2006;7:196-199. [DOI: 10.1383/anes.2006.7.6.196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
556 Pleuvry BJ. Therapeutic problems associated with organ transplantation. Anaesthesia & Intensive Care Medicine 2006;7:193-195. [DOI: 10.1383/anes.2006.7.6.193] [Reference Citation Analysis]
557 Lympholytic Agents (Polyclonal Antilymphocyte Antibodies, Anti-CD3 Monoclonal Antibodies, Anti-CD25 Monoclonal Antibodies). Lung and Heart-Lung Transplantation 2006. [DOI: 10.3109/9781420019285-22] [Reference Citation Analysis]
558 Ogle BM, Platt JL. Xenotransplantation. Wiley Encyclopedia of Biomedical Engineering 2006. [DOI: 10.1002/9780471740360.ebs1580] [Reference Citation Analysis]
559 Lauchart W, Gubernatis G, Blümke M. Transplantationsmedizin. Intensivmedizin und Management bei Organspende und Transplantation. [DOI: 10.1007/3-7985-1611-1_8] [Reference Citation Analysis]
560 Duncan MD, Wilkes DS. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc 2005;2:449-55. [PMID: 16322599 DOI: 10.1513/pats.200507-073JS] [Cited by in Crossref: 73] [Cited by in F6Publishing: 75] [Article Influence: 4.3] [Reference Citation Analysis]
561 Mak TW, Saunders ME. Transplantation. The Immune Response 2006. [DOI: 10.1016/b978-012088451-3.50029-6] [Reference Citation Analysis]
562 Anglicheau D, Zuber J, Martinez F, Méjean A, Patey N, Correas J, Le Quintrec M, Timsit M, Mamzer-bruneel M, Noël L, Thiounn N, Thervet E, Legendre C, Hélénon O. Transplantation rénale : réalisation et complications. EMC - Néphrologie 2006;1:1-19. [DOI: 10.1016/s1762-0945(07)25192-7] [Reference Citation Analysis]
563 Thervet E, Zuber J, Sberro R, Canaud G, Anglicheau D, Snanoudj R, Mamzer-brunel M, Martinez F, Legendre C. Traitements immunosuppresseurs : mécanismes d'action et utilisation clinique. EMC - Néphrologie 2006;1:1-16. [DOI: 10.1016/s1762-0945(09)50344-0] [Reference Citation Analysis]
564 Recommended Reading. Crash Course (US): Immunology 2006. [DOI: 10.1016/b1-416-03007-7/10020-3] [Reference Citation Analysis]
565 Candon S. Transplantation rénale : aspects immunologiques. EMC - Néphrologie 2006;1:1-15. [DOI: 10.1016/s1762-0945(07)41751-x] [Reference Citation Analysis]
566 Budde K, Giessing M, Liefeldt L, Neumayer HH, Glander P. [Modern immunosuppression following renal transplantation. Standard or tailor made?]. Urologe A 2006;45:9-17. [PMID: 16328215 DOI: 10.1007/s00120-005-0958-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
567 Lauchart W, Gubernatis G, Blümke† M. Transplantationsmedizin. Intensivmed 2005;42:481-488. [DOI: 10.1007/s00390-005-0612-y] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
568 Ata B, Friedewald JJ, Randa AC. Organ Transplantation. SSRN Journal. [DOI: 10.2139/ssrn.3010216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]